https://www.pharmaceutical-business-review.com/news/seattle-genetics-pieris-sign-12bn-deal-for-novel-immuno-oncology-treatments-120218-6052703/ 2018-07-04T15:21:12+00:00 https://www.pharmaceutical-business-review.com/news/vivus_presents_positive_results_from_obesity_drug_study_161208/ 2018-07-04T15:21:15+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisks-ozempic-secures-european-approval-for-type-2-diabetes-120218-6052619/ 2018-07-04T15:21:15+00:00 https://www.pharmaceutical-business-review.com/news/scientists-confirm-apalutamide-delays-spread-of-certain-prostate-cancers-120218-6052465/ 2018-07-04T15:21:15+00:00 https://www.pharmaceutical-business-review.com/news/wyeth_reports_positive_results_from_phase_ii_breast_cancer_study_161208/ 2018-07-04T15:21:16+00:00 https://www.pharmaceutical-business-review.com/news/affiris_initiates_preclinical_development_of_parkinsons_vaccine_161208/ 2018-07-04T15:21:16+00:00 https://www.pharmaceutical-business-review.com/news/barrs_bla_for_adenovirus_oral_vaccines_accepted_for_filing_by_fda_161208/ 2018-07-04T15:21:16+00:00 https://www.pharmaceutical-business-review.com/news/rexahn-pharmaceuticals-zhejiang-haichang-biotechnology-to-develop-rx-0201-for-hepatocellular-carcinoma-090218-6051323/ 2018-07-04T15:21:16+00:00 https://www.pharmaceutical-business-review.com/news/capstone_reports_positive_results_from_phase_i_safety_study_in_dermal_scarring_161208/ 2018-07-04T15:21:17+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-label-update-of-novartis-psoriasis-drug-cosentyx-090218-6051151/ 2018-07-04T15:21:18+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-sues-gilead-over-patent-infringement-in-hiv-drug-090218-6051103/ 2018-07-04T15:21:18+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-breakthrough-therapy-designation-for-gsks-meningitis-b-vaccine-bexsero-080218-6050155/ 2018-07-04T15:21:19+00:00 https://www.pharmaceutical-business-review.com/news/4a497cornerstone_pharmaceuticals_raises_6_million_in_fina/ 2018-07-04T15:21:20+00:00 https://www.pharmaceutical-business-review.com/news/ae4b8adeona_expands_patent_portfolio_for_oral_tri/ 2018-07-04T15:21:20+00:00 https://www.pharmaceutical-business-review.com/news/41481omegagenesis_and_mayo_clinic_form_rd_collabor/ 2018-07-04T15:21:21+00:00 https://www.pharmaceutical-business-review.com/news/8248akamada_completes_enrollment_in_phase_ii_bronchiectasis_/ 2018-07-04T15:21:21+00:00 https://www.pharmaceutical-business-review.com/news/1049acardiums_innercool_wins_us_supplier_contract_from_nov/ 2018-07-04T15:21:21+00:00 https://www.pharmaceutical-business-review.com/news/janssen-theravance-to-develop-and-commercialise-td-1473-for-inflammatory-intestinal-diseases-080218-6050054/ 2018-07-04T15:21:22+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-brilinta-succeeds-in-phase-3-trial-in-people-with-multi-vessel-disease-080218-6050007/ 2018-07-04T15:21:22+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-gileads-biktarvy-triple-therapy-treatment-for-hiv-1-080218-6049793/ 2018-07-04T15:21:22+00:00 https://www.pharmaceutical-business-review.com/news/zogenix-secures-fda-breakthrough-therapy-designation-for-zx008-in-dravet-syndrome-070218-6048836/ 2018-07-04T15:21:24+00:00 https://www.pharmaceutical-business-review.com/news/2b49chawaii_biotech_completes_dosing_in_phase_i_west_nile_virus_vaccine_/ 2018-07-04T15:21:24+00:00 https://www.pharmaceutical-business-review.com/news/netvation-dl-medicine-enters-into-research-collaboration-with-pfizer-070218-6048675/ 2018-07-04T15:21:25+00:00 https://www.pharmaceutical-business-review.com/news/roches-tecentriq-plus-avastin-succeeds-in-phase-3-kidney-cancer-trial-070218-6048378/ 2018-07-04T15:21:25+00:00 https://www.pharmaceutical-business-review.com/news/3c498rti_biologics_and_entrigue_sign_development_and_supply_agre/ 2018-07-04T15:21:25+00:00 https://www.pharmaceutical-business-review.com/news/4e484neuroptix_names_ne/ 2018-07-04T15:21:25+00:00 https://www.pharmaceutical-business-review.com/news/d54b3huya_bioscience_forms_collaboration_with_scheringp/ 2018-07-04T15:21:25+00:00 https://www.pharmaceutical-business-review.com/news/ed4b9cerus_extends_manufacturing_agreement_with_f/ 2018-07-04T15:21:25+00:00 https://www.pharmaceutical-business-review.com/news/c44aelife_technologies_names_new_board_m/ 2018-07-04T15:21:29+00:00 https://www.pharmaceutical-business-review.com/news/834aeorthofix_and_mtf_complete_milestone_in_allograft_develo/ 2018-07-04T15:21:29+00:00 https://www.pharmaceutical-business-review.com/news/a04b8transpharma_wins_ce_mark_for_viaderm_transdermal_drug_delivery_d/ 2018-07-04T15:21:29+00:00 https://www.pharmaceutical-business-review.com/news/scientists-studying-potential-of-old-compounds-to-develop-new-antibiotics-070218-6048979/ 2018-07-04T15:21:29+00:00 https://www.pharmaceutical-business-review.com/news/capricor-gets-fda-rmat-designation-for-cap-1002-to-treat-duchenne-muscular-dystrophy-therapy-060218-6047406/ 2018-07-04T15:21:29+00:00 https://www.pharmaceutical-business-review.com/news/shields-ida-treatment-fails-to-meet-primary-endpoint-in-aegis-ckd-phase-iii-study-060218-6047286/ 2018-07-04T15:21:29+00:00 https://www.pharmaceutical-business-review.com/news/634bdyissums_subsidiary_signs_rd_collaboration_agreement_with/ 2018-07-04T15:21:30+00:00 https://www.pharmaceutical-business-review.com/news/7d48aproteonomixs_subsidiary_signs_loi_with_sino/ 2018-07-04T15:21:30+00:00 https://www.pharmaceutical-business-review.com/news/da4b1astrazeneca_files_snda_for_seroqu/ 2018-07-04T15:21:32+00:00 https://www.pharmaceutical-business-review.com/news/834bfarenas_partner_orthomcneiljanssen_initiates_phase_i_diabetes_tr/ 2018-07-04T15:21:33+00:00 https://www.pharmaceutical-business-review.com/news/ema-to-review-gws-maa-for-antiepileptic-drug-epidiolex-060218-6047231/ 2018-07-04T15:21:33+00:00 https://www.pharmaceutical-business-review.com/news/804a6fibrogen_initiates_phase_i_pancreatic_cancer_/ 2018-07-04T15:21:34+00:00 https://www.pharmaceutical-business-review.com/news/7749aspectranetics_wins_clearance_for_new_crosspilot_cat/ 2018-07-04T15:21:34+00:00 https://www.pharmaceutical-business-review.com/news/64496synvista_initiates_dosing_in_phase_ii_psoriasis_/ 2018-07-04T15:21:34+00:00 https://www.pharmaceutical-business-review.com/news/4548aacacia_researchs_subsidiary_settles_patent_litigation_with_philips_electr/ 2018-07-04T15:21:34+00:00 https://www.pharmaceutical-business-review.com/news/bms-opdivo-yervoy-succeeds-in-phase-3-lung-cancer-trial-060218-6046995/ 2018-07-04T15:21:34+00:00 https://www.pharmaceutical-business-review.com/news/pharmabcine-merck-to-assess-ttac-0001-in-combination-with-keytruda-in-recurrent-rlioblastoma-and-breast-cancer-050218-6045971/ 2018-07-04T15:21:34+00:00 https://www.pharmaceutical-business-review.com/news/teva-seeks-european-approval-for-migraine-drug-fremanezumab-050218-6045741/ 2018-07-04T15:21:37+00:00 https://www.pharmaceutical-business-review.com/news/n4-pharma-secures-innovate-uk-grant-for-collaboration-project-with-medimmune-050218-6045983/ 2018-07-04T15:21:37+00:00 https://www.pharmaceutical-business-review.com/news/partner-therapeutics-to-develop-and-commercialise-sanofis-leukine-immuno-stimulant-020218-6044673/ 2018-07-04T15:21:38+00:00 https://www.pharmaceutical-business-review.com/news/1949dprogenitor_cell_therapy_names_ne/ 2018-07-04T15:21:38+00:00 https://www.pharmaceutical-business-review.com/news/6048blife_technologies_to_develop_new_human_stem_cell_disease_m/ 2018-07-04T15:21:38+00:00 https://www.pharmaceutical-business-review.com/news/fd487cylene_initiates_phase_ii_cancer_/ 2018-07-04T15:21:38+00:00 https://www.pharmaceutical-business-review.com/news/934b4metabasiss_president_and_ceo_re/ 2018-07-04T15:21:38+00:00 https://www.pharmaceutical-business-review.com/news/somnus_completes_phase_i_study_of_sleep_maintenance_drug_151208/ 2018-07-04T15:21:39+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-avycaz-to-treat-hospital-acquired-bacterial-pneumonia-and-ventilator-associated-bacterial-pneumonia-020218-6044690/ 2018-07-04T15:21:41+00:00 https://www.pharmaceutical-business-review.com/news/cvc-capital-launches-new-uk-based-specialty-pharmaceutical-company-020118-6044426/ 2018-07-04T15:21:41+00:00 https://www.pharmaceutical-business-review.com/news/syndax-astrazeneca-to-trial-durvalumab-sndx-6352-combination-in-solid-tumors-020218-6044701/ 2018-07-04T15:21:42+00:00 https://www.pharmaceutical-business-review.com/news/seattle_genetics_completes_safety_review_for_phase_iib_leukemia_trial_151208/ 2018-07-04T15:21:43+00:00 https://www.pharmaceutical-business-review.com/news/psivida_announces_pilot_study_for_new_drug_delivery_device_in_amd_151208/ 2018-07-04T15:21:43+00:00 https://www.pharmaceutical-business-review.com/news/polymedix_completes_phase_i_safety_study_of_new_antibiotic_drug_151208/ 2018-07-04T15:21:44+00:00 https://www.pharmaceutical-business-review.com/news/helsinn_healthcare_and_zealand_pharma_partner_in_diarrhea_drug_development_151208/ 2018-07-04T15:21:44+00:00 https://www.pharmaceutical-business-review.com/news/valeant_to_acquire_dow_pharmaceutical_sciences_for_285_million_151208/ 2018-07-04T15:21:44+00:00 https://www.pharmaceutical-business-review.com/news/new-organ-on-a-chip-technology-to-study-blood-vessel-formation-and-anti-cancer-effects-010218-6043747/ 2018-07-04T15:21:45+00:00 https://www.pharmaceutical-business-review.com/news/juniper-pharmaceuticals-to-explore-strategic-alternatives-010218-6043474/ 2018-07-04T15:21:46+00:00 https://www.pharmaceutical-business-review.com/news/sage-reports-positive-results-for-sage-217-in-early-stage-insomnia-trial-010218-6043300/ 2018-07-04T15:21:46+00:00 https://www.pharmaceutical-business-review.com/news/panacos_axes_18_jobs_151208/ 2018-07-04T15:21:48+00:00 https://www.pharmaceutical-business-review.com/news/napo_licenses_diarrhea_drug_to_salix_pharmaceuticals_151208/ 2018-07-04T15:21:49+00:00 https://www.pharmaceutical-business-review.com/news/kai_pharmaceuticals_initiates_phase_iia_postoperative_pain_study_151208/ 2018-07-04T15:21:49+00:00 https://www.pharmaceutical-business-review.com/news/gt_initiates_premarket_approval_process_for_cancer_detection_device_151208/ 2018-07-04T15:21:49+00:00 https://www.pharmaceutical-business-review.com/news/fda_panel_rejects_acuspheres_heart_imaging_drug_151208/ 2018-07-04T15:21:49+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-to-acquire-cascadian-therapeutics-for-614m-010218-6043005/ 2018-07-04T15:21:49+00:00 https://www.pharmaceutical-business-review.com/news/amgen-receives-chmp-positive-opinion-to-add-updated-overall-survival-data-to-kyprolis-label-310118-6041940/ 2018-07-04T15:21:50+00:00 https://www.pharmaceutical-business-review.com/news/bridgebio-pharma-licenses-oncology-drug-infigratinib-from-novartis-310118-6041926/ 2018-07-04T15:21:50+00:00 https://www.pharmaceutical-business-review.com/news/crucells_new_influenza_antibody_found_to_be_effective_in_preclinical_study_151208/ 2018-07-04T15:21:52+00:00 https://www.pharmaceutical-business-review.com/news/celgene_reports_promising_data_from_phase_ii_myeloma_study_151208/ 2018-07-04T15:21:52+00:00 https://www.pharmaceutical-business-review.com/news/49498eisai_wins_fda_approval_for_anesthesia/ 2018-07-04T15:21:52+00:00 https://www.pharmaceutical-business-review.com/news/e849csanofiaventis_and_bristolmyers_win_plavix_patent_infringement/ 2018-07-04T15:21:53+00:00 https://www.pharmaceutical-business-review.com/news/4448fsemprus_raises_8_million_in_series_a_fina/ 2018-07-04T15:21:53+00:00 https://www.pharmaceutical-business-review.com/news/fda-orders-clinical-hold-on-bellicums-us-trials-of-bpx-501-cell-therapy-310118-6041621/ 2018-07-04T15:21:53+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-to-takedas-zika-virus-vaccine-candidate-300118-6040644/ 2018-07-04T15:21:53+00:00 https://www.pharmaceutical-business-review.com/news/innate-pharma-medimmune-enter-clinical-trial-collaboration-300118-6040727/ 2018-07-04T15:21:54+00:00 https://www.pharmaceutical-business-review.com/news/7c4afpfizer_reports_results_from_planned_analysis_of_breast_cancer_/ 2018-07-04T15:21:56+00:00 https://www.pharmaceutical-business-review.com/news/sillajen-initiates-phase-12-trial-of-pexa-vec-in-metastatic-colon-cancer-300118-6040531/ 2018-07-04T15:21:56+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-to-acquire-belgian-biotech-ablynx-for-eur39bn-300118-6040365/ 2018-07-04T15:21:56+00:00 https://www.pharmaceutical-business-review.com/news/c44b3par_pharmaceuticals_cfo_to_r/ 2018-07-04T15:21:57+00:00 https://www.pharmaceutical-business-review.com/news/8a485scheringplough_wins_fda_approval_for_hepatitis_combination_th/ 2018-07-04T15:21:57+00:00 https://www.pharmaceutical-business-review.com/news/c04b9ablynx_reports_positive_results_from_phase_ib_study_of_antithrombotic/ 2018-07-04T15:21:57+00:00 https://www.pharmaceutical-business-review.com/news/4a4a1akorn_wins_fda_approval_for_ciprofloxacin_hcl_ophthalmic_sol/ 2018-07-04T15:21:57+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-pt010-triple-combination-therapy-shows-significant-effect-in-copd-trial-290118-6039561/ 2018-07-04T15:21:57+00:00 https://www.pharmaceutical-business-review.com/news/spectris-acquires-concept-life-sciences-for-163m-290118-6039343/ 2018-07-04T15:22:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-radioactive-drug-lutathera-for-certain-digestive-tract-cancers-290118-6039225/ 2018-07-04T15:22:00+00:00 https://www.pharmaceutical-business-review.com/news/rexgenero-launches-phase-3-critical-limb-ischemia-program-for-rex-001-260118-6037105/ 2018-07-04T15:22:00+00:00 https://www.pharmaceutical-business-review.com/news/e448amercks_snda_for_hiv_drug_accepted_for_review_b/ 2018-07-04T15:22:02+00:00 https://www.pharmaceutical-business-review.com/news/aa4b6bridgegate_and_healthation_sign_oem_agreem/ 2018-07-04T15:22:02+00:00 https://www.pharmaceutical-business-review.com/news/cb4b7ym_biosciences_wins_milestone_payment_from_innogene_kalbi/ 2018-07-04T15:22:02+00:00 https://www.pharmaceutical-business-review.com/news/7149bbanyan_biomarkers_wins_new_us_patent_for_traumatic_i/ 2018-07-04T15:22:03+00:00 https://www.pharmaceutical-business-review.com/news/1b48aelan_likely_to_cut_job/ 2018-07-04T15:22:03+00:00 https://www.pharmaceutical-business-review.com/news/synthons-vic-trastuzumab-duocarmazine-syd985-granted-fda-fast-track-designation-for-pre-treated-her2-positive-metastatic-breast-cancer-6037284/ 2018-07-04T15:22:03+00:00 https://www.pharmaceutical-business-review.com/news/alligator-appoints-theradex-oncology-as-clinical-cro-for-ator-1015-phase-i-study-6037285/ 2018-07-04T15:22:03+00:00 https://www.pharmaceutical-business-review.com/news/solanezumab-fails-to-slow-cognitive-decline-in-alzheimers-disease-study-250118-6036642/ 2018-07-04T15:22:03+00:00 https://www.pharmaceutical-business-review.com/news/5149fgilead_files_patent_infringement_lawsuit_against_teva_pharmaceut/ 2018-07-04T15:22:06+00:00 https://www.pharmaceutical-business-review.com/news/85491momenta_to_secure_241_million_through_registered_direct_off/ 2018-07-04T15:22:06+00:00 https://www.pharmaceutical-business-review.com/news/eb4b4terumo_and_maquet_cardiovascular_settle_patent_litiga/ 2018-07-04T15:22:06+00:00 https://www.pharmaceutical-business-review.com/news/shire-secures-fda-approval-for-technology-transfer-of-cinryze-manufacturing-process-250118-6036613/ 2018-07-04T15:22:06+00:00 https://www.pharmaceutical-business-review.com/news/oxford-biomedica-a-secures-3m-grant-from-innovate-uk-250118-6036655/ 2018-07-04T15:22:06+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-rituximab-biosimilar-found-to-be-effective-in-lymphoma-trial-250118-6036406/ 2018-07-04T15:22:06+00:00 https://www.pharmaceutical-business-review.com/news/164b8aetna_to_provide_outpatient_services_in_/ 2018-07-04T15:22:07+00:00 https://www.pharmaceutical-business-review.com/news/874a9abraxis_reports_positive_preliminary_results_from_phase_ii_breast_cancer_/ 2018-07-04T15:22:07+00:00 https://www.pharmaceutical-business-review.com/news/ge-to-provide-biomanufacturing-platform-for-clovers-new-chinese-facility-240118-6035304/ 2018-07-04T15:22:09+00:00 https://www.pharmaceutical-business-review.com/news/dandrit-to-acquire-enochian-biopharma-240118-6035313/ 2018-07-04T15:22:09+00:00 https://www.pharmaceutical-business-review.com/news/astellas-gilteritinib-gets-orphan-designation-in-europe-for-acute-myeloid-leukaemia-240118-6035236/ 2018-07-04T15:22:09+00:00 https://www.pharmaceutical-business-review.com/news/214bepfizer_to_axe_700_jobs_in_f/ 2018-07-04T15:22:10+00:00 https://www.pharmaceutical-business-review.com/news/c248efhcs_fc2_female_condom_wins_positive_recommendation_from_fda_/ 2018-07-04T15:22:11+00:00 https://www.pharmaceutical-business-review.com/news/b34b5alfacells_president_and_cfo_re/ 2018-07-04T15:22:11+00:00 https://www.pharmaceutical-business-review.com/news/c44a3access_mediquip_and_wellpoint_sign_contract_for_implantable_medical_de/ 2018-07-04T15:22:11+00:00 https://www.pharmaceutical-business-review.com/news/bc4a6medline_named_authorized_distributor_for_healthtrust_purchasing_/ 2018-07-04T15:22:11+00:00 https://www.pharmaceutical-business-review.com/news/sobis-mps-iiia-drug-candidate-secures-fast-track-status-in-us-240118-6035083/ 2018-07-04T15:22:13+00:00 https://www.pharmaceutical-business-review.com/news/celgene-to-buy-juno-therapeutics-for-9bn-230118-6034336/ 2018-07-04T15:22:14+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-yervoy-secures-european-approval-for-pediatric-melanoma-230118-6034125/ 2018-07-04T15:22:14+00:00 https://www.pharmaceutical-business-review.com/news/444aaalgeta_names_new_president_an/ 2018-07-04T15:22:14+00:00 https://www.pharmaceutical-business-review.com/news/affymetrix_acquires_panomics_121208/ 2018-07-04T15:22:15+00:00 https://www.pharmaceutical-business-review.com/news/pfizer_and_sigma_tau_partner_to_market_malaria_drug_in_africa_121208/ 2018-07-04T15:22:15+00:00 https://www.pharmaceutical-business-review.com/news/mercks_kuvan_wins_marketing_approval_in_eu_121208/ 2018-07-04T15:22:15+00:00 https://www.pharmaceutical-business-review.com/news/md_biosciences_launches_new_antibodies_for_eye_and_cornea_research_121208/ 2018-07-04T15:22:15+00:00 https://www.pharmaceutical-business-review.com/news/abcam-signs-deal-with-roche-to-obtain-exclusive-rights-to-spring-bioscience-product-portfolio-230118-6034171/ 2018-07-04T15:22:28+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-to-acquire-hemophilia-specialist-bioverativ-for-116bn-230118-6033868/ 2018-07-04T15:22:28+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-for-daratumumab-in-front-line-multiple-myeloma-220118-6033099/ 2018-07-04T15:22:29+00:00 https://www.pharmaceutical-business-review.com/news/hemaquest_completes_phase_i_studies_of_blood_disorder_drug_121208/ 2018-07-04T15:22:30+00:00 https://www.pharmaceutical-business-review.com/news/gpc_biotech_initiates_enrollment_in_phase_i_study_of_antitumor_drug_121208/ 2018-07-04T15:22:30+00:00 https://www.pharmaceutical-business-review.com/news/gloucester_reports_positive_interim_results_from_phase_iii_myeloma_study_121208/ 2018-07-04T15:22:31+00:00 https://www.pharmaceutical-business-review.com/news/callistos_subsidiary_completes_phase_i_study_of_constipation_drug_121208/ 2018-07-04T15:22:31+00:00 https://www.pharmaceutical-business-review.com/news/axial_biotech_introduces_new_genetic_test_for_adolescent_idiopathic_scoliosis_121208/ 2018-07-04T15:22:31+00:00 https://www.pharmaceutical-business-review.com/news/symbio-begins-phase-1-trial-for-treakisym-in-progressive-solid-tumors-220118-6033016/ 2018-07-04T15:22:32+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-secures-japanese-approvals-for-cancer-and-asthma-drugs-220118-6032733/ 2018-07-04T15:22:32+00:00 https://www.pharmaceutical-business-review.com/news/immupharma-completes-pivotal-phase-3-trial-of-lupus-drug-190118-6031914/ 2018-07-04T15:22:32+00:00 https://www.pharmaceutical-business-review.com/news/apthera_to_initiate_phase_iii_trials_of_lyophilized_cancer_drug_formulation_121208/ 2018-07-04T15:22:34+00:00 https://www.pharmaceutical-business-review.com/news/almac-to-further-expand-ireland-campus-with-30m-investment-190118-6031902/ 2018-07-04T15:22:35+00:00 https://www.pharmaceutical-business-review.com/news/cgt-catapult-enters-into-viral-vector-manufacturing-technology-collaboration-with-freeline-therapeutics-190118-6031476/ 2018-07-04T15:22:35+00:00 https://www.pharmaceutical-business-review.com/news/82496novaray_names_ne/ 2018-07-04T15:22:35+00:00 https://www.pharmaceutical-business-review.com/news/f7489rosetta_genomics_launches_new_lung_cancer/ 2018-07-04T15:22:35+00:00 https://www.pharmaceutical-business-review.com/news/0c4bdscynexis_and_dndi_extend_rd_collabor/ 2018-07-04T15:22:35+00:00 https://www.pharmaceutical-business-review.com/news/uspto-invalidates-jjs-patent-on-prostate-cancer-drug-zytiga-180118-6031316/ 2018-07-04T15:22:36+00:00 https://www.pharmaceutical-business-review.com/news/0e48dhealionics_secures_26_million_in_series_b_fina/ 2018-07-04T15:22:36+00:00 https://www.pharmaceutical-business-review.com/news/x-chem-astrazeneca-expand-drug-discovery-partnership-180118-6030914/ 2018-07-04T15:22:39+00:00 https://www.pharmaceutical-business-review.com/news/carmot-therapeutics-secures-funding-for-type-2-diabetes-drug-6030932/ 2018-07-04T15:22:39+00:00 https://www.pharmaceutical-business-review.com/news/novartis-kymriah-secures-fast-tracked-reviews-for-lymphoma-in-us-europe-180118-6030701/ 2018-07-04T15:22:39+00:00 https://www.pharmaceutical-business-review.com/news/544bfprostrakan_wins_german_marketing_approval_for_cancer_pain/ 2018-07-04T15:22:39+00:00 https://www.pharmaceutical-business-review.com/news/c84bdinfinity_reacquires_rights_to_cancer_drug_pr/ 2018-07-04T15:22:39+00:00 https://www.pharmaceutical-business-review.com/news/314a3hovione_to_acquire_pfizers_loughbeg_api_fac/ 2018-07-04T15:22:39+00:00 https://www.pharmaceutical-business-review.com/news/6649bbicoastal_pharmaceutical_gains_us_marketing_rights_to_xerostomia/ 2018-07-04T15:22:39+00:00 https://www.pharmaceutical-business-review.com/news/83489genomma_lab_launches_new_personal_hair_care_product/ 2018-07-04T15:22:40+00:00 https://www.pharmaceutical-business-review.com/news/sandoz-regulatory-submission-for-proposed-biosimilar-adalimumab-accepted-by-fda-170118-6029630/ 2018-07-04T15:22:42+00:00 https://www.pharmaceutical-business-review.com/news/shires-adynov-secures-approval-for-hemophilia-a-in-europe-170118-6029588/ 2018-07-04T15:22:42+00:00 https://www.pharmaceutical-business-review.com/news/mercks-keytruda-regimen-succeeds-in-phase-3-nsclc-trial-170118-6029342/ 2018-07-04T15:22:42+00:00 https://www.pharmaceutical-business-review.com/news/ab4bfpra_international_opens_new_facility_in_m/ 2018-07-04T15:22:42+00:00 https://www.pharmaceutical-business-review.com/news/0748csorin_group_launches_new_defibrillation_leads_in_/ 2018-07-04T15:22:43+00:00 https://www.pharmaceutical-business-review.com/news/nutra_pharma_wins_clinical_drug_supply_contract_from_celtic_biotech_111208/ 2018-07-04T15:22:43+00:00 https://www.pharmaceutical-business-review.com/news/novartis_reports_positive_results_from_two_phase_ii_studies_of_leukemia_drug_111208/ 2018-07-04T15:22:43+00:00 https://www.pharmaceutical-business-review.com/news/micromet_presents_encouraging_interim_data_from_phase_ii_leukemia_study_111208/ 2018-07-04T15:22:43+00:00 https://www.pharmaceutical-business-review.com/news/midatech-gets-fda-ind-approval-to-begin-trial-of-brain-cancer-treatment-170118-6029992/ 2018-07-04T15:22:44+00:00 https://www.pharmaceutical-business-review.com/news/mundipharma-agrees-to-distribute-grnenthals-pain-relief-drug-in-china-160118-6028457/ 2018-07-04T15:22:45+00:00 https://www.pharmaceutical-business-review.com/news/e-therapeutics-signs-two-collaboration-deals-to-enhance-ai-technology-capabilities-160118-6028409/ 2018-07-04T15:22:45+00:00 https://www.pharmaceutical-business-review.com/news/inovio_and_vgx_pharmaceuticals_amend_merger_agreement_111208/ 2018-07-04T15:22:46+00:00 https://www.pharmaceutical-business-review.com/news/avacta-signs-licensing-deal-with-glythera-after-successful-trial-160118-6028356/ 2018-07-04T15:22:47+00:00 https://www.pharmaceutical-business-review.com/news/telix-pharmaceuticals-establishes-japanese-subsidiary-160118-6028350/ 2018-07-04T15:22:47+00:00 https://www.pharmaceutical-business-review.com/news/immunomedics_reports_encouraging_initial_results_from_phase_iii_itp_study_111208/ 2018-07-04T15:22:47+00:00 https://www.pharmaceutical-business-review.com/news/immunogen_reports_favorable_data_from_phase_i_multiple_myeloma_study_111208/ 2018-07-04T15:22:47+00:00 https://www.pharmaceutical-business-review.com/news/hana_biosciences_completes_phase_i_study_of_menadione_topical_lotion_111208/ 2018-07-04T15:22:47+00:00 https://www.pharmaceutical-business-review.com/news/halozymes_partner_roche_initiates_phase_i_pharmacokinetic_clinical_study_111208/ 2018-07-04T15:22:47+00:00 https://www.pharmaceutical-business-review.com/news/vaccitech-secures-investment-from-google-and-others-for-universal-flu-vaccine-160118-6028085/ 2018-07-04T15:22:48+00:00 https://www.pharmaceutical-business-review.com/news/geron_reports_positive_interim_results_from_phase_i_myeloma_trial_111208/ 2018-07-04T15:22:51+00:00 https://www.pharmaceutical-business-review.com/news/forest_laboratories_and_cypress_report_positive_results_from_fibromyalgia_study_111208/ 2018-07-04T15:22:51+00:00 https://www.pharmaceutical-business-review.com/news/eisai_reports_encouraging_data_from_phase_ii_leukemia_trial_111208/ 2018-07-04T15:22:51+00:00 https://www.pharmaceutical-business-review.com/news/curiss_partner_genentech_initiates_phase_ii_ovarian_cancer_study_111208/ 2018-07-04T15:22:51+00:00 https://www.pharmaceutical-business-review.com/news/cgt-catapult-to-support-combigenes-gene-therapy-for-epilepsy-150118-6027260/ 2018-07-04T15:22:51+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-lynparza-in-germline-brca-mutated-metastatic-breast-cancer-6028433/ 2018-07-04T15:22:51+00:00 https://www.pharmaceutical-business-review.com/news/endo-comments-on-us-attorneys-office-grand-jury-subpoena-relating-to-products-containing-oxymorphone-120118-6026768/ 2018-07-04T15:22:51+00:00 https://www.pharmaceutical-business-review.com/news/cambridge_laboratories_wins_marketing_approval_for_huntingtons_drug_in_spain_111208/ 2018-07-04T15:22:52+00:00 https://www.pharmaceutical-business-review.com/news/calistogas_antitumor_drug_demonstrates_preclinical_activity_in_cancer_cells_111208/ 2018-07-04T15:22:53+00:00 https://www.pharmaceutical-business-review.com/news/bristol_myers_and_astrazeneca_expand_diabetes_drug_collaboration_111208/ 2018-07-04T15:22:54+00:00 https://www.pharmaceutical-business-review.com/news/biosante_signs_marketing_agreement_with_pharmaswiss_111208/ 2018-07-04T15:22:54+00:00 https://www.pharmaceutical-business-review.com/news/industry_leaders_to_discuss_growth_strategies_for_pharma_industry_111208/ 2018-07-04T15:22:54+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas_phase_iib_schizophrenia_study_fails_endpoint_111208/ 2018-07-04T15:22:54+00:00 https://www.pharmaceutical-business-review.com/news/charles-river-acquires-uk-based-cro-kws-biotest-120118-6026507/ 2018-07-04T15:22:55+00:00 https://www.pharmaceutical-business-review.com/news/fda-panel-votes-against-approval-of-lipocines-testosterone-replacement-therapy-120118-6027310/ 2018-07-04T15:22:55+00:00 https://www.pharmaceutical-business-review.com/news/allergy-therapeutics-completes-patient-recruitment-in-pq-birch-phase-iii-clinical-trial-110118-6025494/ 2018-07-04T15:22:55+00:00 https://www.pharmaceutical-business-review.com/news/antisoma_presents_positive_data_from_phase_ii_leukemia_study_111208/ 2018-07-04T15:22:57+00:00 https://www.pharmaceutical-business-review.com/news/alexion_reports_positive_results_from_blood_disorder_drug_study_111208/ 2018-07-04T15:22:58+00:00 https://www.pharmaceutical-business-review.com/news/db48enuvelo_reports_positive_results_from_phase_i_study_of_new_recombinant_pr/ 2018-07-04T15:22:58+00:00 https://www.pharmaceutical-business-review.com/news/934aemorphosys_names_new_chief_development_of/ 2018-07-04T15:22:58+00:00 https://www.pharmaceutical-business-review.com/news/d44b3aspenbio_completes_enrollment_in_clinical_study_of_appendicitis/ 2018-07-04T15:22:58+00:00 https://www.pharmaceutical-business-review.com/news/amryt-signs-lojuxta-distribution-agreement-with-grynumber-110118-6025405/ 2018-07-04T15:22:58+00:00 https://www.pharmaceutical-business-review.com/uncategorized/researchers-develop-reusable-stinging-nettle-treatment-to-target-cancer-cells-110118-6025396/ 2018-07-04T15:22:58+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-fasenra-gets-approval-in-europe-for-severe-eosinophilic-asthma-110118-6025143/ 2018-07-04T15:22:59+00:00 https://www.pharmaceutical-business-review.com/news/5e4a0patheon_establishes_new_us_headquarters_in_north_car/ 2018-07-04T15:23:02+00:00 https://www.pharmaceutical-business-review.com/news/bergenbio-meets-first-efficacy-endpoint-in-phase-ii-trial-with-selective-axl-inhibitor-bgb324-in-nsclc-100118-6024186/ 2018-07-04T15:23:02+00:00 https://www.pharmaceutical-business-review.com/news/inovio-parker-institute-to-jointly-evaluate-cancer-immunotherapy-combinations-100918-6024042/ 2018-07-04T15:23:02+00:00 https://www.pharmaceutical-business-review.com/news/axovant-to-stop-development-of-lead-dementia-drug-after-negative-results-090118-6023715/ 2018-07-04T15:23:02+00:00 https://www.pharmaceutical-business-review.com/news/8a499halozyme_initiates_phase_i_study_of_bisphosphonate_pr/ 2018-07-04T15:23:03+00:00 https://www.pharmaceutical-business-review.com/news/07485symbollon_signs_sale_and_licensing_agreement_with_biocide_p/ 2018-07-04T15:23:03+00:00 https://www.pharmaceutical-business-review.com/news/7f492daiichi_sankyo_files_for_japanese_approval_of_antihypertensive_combination/ 2018-07-04T15:23:03+00:00 https://www.pharmaceutical-business-review.com/news/ff4b4evotecs_president_and_ceo_re/ 2018-07-04T15:23:03+00:00 https://www.pharmaceutical-business-review.com/news/e44b2telesso_and_vpi_partner_for_guidewireassisted_catheter_/ 2018-07-04T15:23:05+00:00 https://www.pharmaceutical-business-review.com/news/e14bdalnylam_forms_collaboration_with_ucsf_for_development_of_melanoma/ 2018-07-04T15:23:05+00:00 https://www.pharmaceutical-business-review.com/news/d44a2national_jewish_health_and_labcorp_sign_collaboration_agre/ 2018-07-04T15:23:06+00:00 https://www.pharmaceutical-business-review.com/news/684afmisonix_extends_distribution_agreement_with_m/ 2018-07-04T15:23:06+00:00 https://www.pharmaceutical-business-review.com/news/a348b3m_licenses_cambridge_consultantss_dry_powder_inhaler_techn/ 2018-07-04T15:23:06+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-forms-consortium-to-accelerate-sequencing-of-uk-biobank-data-100118-6025520/ 2018-07-04T15:23:06+00:00 https://www.pharmaceutical-business-review.com/news/lipocine-announces-outcome-of-fda-advisory-committee-meeting-for-tlando-testosterone-replacement-therapy-in-adult-males-with-hypogonadism_110893-6026183/ 2018-07-04T15:23:07+00:00 https://www.pharmaceutical-business-review.com/news/mallinckrodt-agrees-to-sell-hemostasis-products-to-baxter-090118-6022631/ 2018-07-04T15:23:07+00:00 https://www.pharmaceutical-business-review.com/news/f84a2proteo_and_minapharm_win_egyptian_approval_for_phase_ii_kidney_transplant_/ 2018-07-04T15:23:09+00:00 https://www.pharmaceutical-business-review.com/news/14489icon_introduces_new_cardiac_imaging_sof/ 2018-07-04T15:23:10+00:00 https://www.pharmaceutical-business-review.com/news/4c4a4fresenius_medical_care_opens_new_dialysis_clinic_in_san_bernardino_calif/ 2018-07-04T15:23:10+00:00 https://www.pharmaceutical-business-review.com/news/cb4baatcor_medical_wins_new_pharmaceutical_trial_cont/ 2018-07-04T15:23:10+00:00 https://www.pharmaceutical-business-review.com/news/80488china_aoxing_obtains_new_production_license_for_pain_med/ 2018-07-04T15:23:10+00:00 https://www.pharmaceutical-business-review.com/news/abbvies-upadacitinib-gets-fda-breakthrough-designation-for-atopic-dermatitis-090118-6022553/ 2018-07-04T15:23:10+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-rejects-26bn-takeover-offer-from-novo-nordisk-090118-6022271/ 2018-07-04T15:23:10+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-xgeva-to-prevent-skeletal-related-events-in-patients-with-multiple-myeloma-080118-6021328/ 2018-07-04T15:23:10+00:00 https://www.pharmaceutical-business-review.com/news/91484diagnoplex_raises_83_million_in_series_a_fina/ 2018-07-04T15:23:13+00:00 https://www.pharmaceutical-business-review.com/news/avexa_completes_recruitment_for_first_component_of_phase_iii_hiv_trial_101208/ 2018-07-04T15:23:13+00:00 https://www.pharmaceutical-business-review.com/news/sosei_reports_positive_results_from_two_phase_i_neuropathic_pain_trials_101208/ 2018-07-04T15:23:14+00:00 https://www.pharmaceutical-business-review.com/news/seattle_genetics_reports_positive_results_from_phase_ii_lymphoma_trial_101208/ 2018-07-04T15:23:14+00:00 https://www.pharmaceutical-business-review.com/news/seattle_genetics_reports_encouraging_results_from_phase_i_lymphoma_trial_101208/ 2018-07-04T15:23:14+00:00 https://www.pharmaceutical-business-review.com/news/researchers-develop-new-tool-to-assess-racemisation-risk-in-drugs-080118-6021271/ 2018-07-04T15:23:14+00:00 https://www.pharmaceutical-business-review.com/news/celgene-to-acquire-impact-biomedicines-for-11bn-upfront-080118-6021241/ 2018-07-04T15:23:14+00:00 https://www.pharmaceutical-business-review.com/news/takeda-proposes-to-acquire-cell-therapy-firm-tigenix-for-euro520m-080118-6021057/ 2018-07-04T15:23:15+00:00 https://www.pharmaceutical-business-review.com/news/sanofi_aventiss_hyperuricemia_drug_found_to_be_effective_in_phase_iii_study_101208/ 2018-07-04T15:23:17+00:00 https://www.pharmaceutical-business-review.com/news/biontech-raises-270m-in-new-round-of-funding-040118-6019763/ 2018-07-04T15:23:17+00:00 https://www.pharmaceutical-business-review.com/news/rhei_pharmaceuticals_initiates_oral_candidiasis_study_in_china_101208/ 2018-07-04T15:23:18+00:00 https://www.pharmaceutical-business-review.com/news/osiris_wins_canadian_approval_for_prochymal_expanded_access_program_101208/ 2018-07-04T15:23:18+00:00 https://www.pharmaceutical-business-review.com/news/ortho_mcneil_reports_positive_results_from_phase_iii_seizure_trial_101208/ 2018-07-04T15:23:18+00:00 https://www.pharmaceutical-business-review.com/news/ore_pharmaceuticals_completes_dosing_in_phase_i_ibd_study_101208/ 2018-07-04T15:23:18+00:00 https://www.pharmaceutical-business-review.com/news/sangamo-pfizer-collaborate-to-develop-zinc-finger-protein-gene-therapy-for-als-050118-6019879/ 2018-07-04T15:23:18+00:00 https://www.pharmaceutical-business-review.com/news/novartiss-promacta-gets-fda-breakthrough-designation-for-severe-aplastic-anemia-050118-6019507/ 2018-07-04T15:23:18+00:00 https://www.pharmaceutical-business-review.com/news/8549dnice_to_consider_offering_new_service_to_aid_product_develo/ 2018-07-04T15:23:20+00:00 https://www.pharmaceutical-business-review.com/news/oncoscience_withdraws_marketing_application_for_anticancer_drug_101208/ 2018-07-04T15:23:21+00:00 https://www.pharmaceutical-business-review.com/news/millennium_reports_positive_safety_data_from_phase_i_myeloma_study_101208/ 2018-07-04T15:23:21+00:00 https://www.pharmaceutical-business-review.com/news/gsk_reports_positive_results_from_phase_iii_study_of_platelet_drug_101208/ 2018-07-04T15:23:22+00:00 https://www.pharmaceutical-business-review.com/news/genentech_and_biogen_report_positive_results_from_two_phase_iii_leukemia_trials_101208/ 2018-07-04T15:23:22+00:00 https://www.pharmaceutical-business-review.com/news/exelixis_reports_positive_results_from_phase_i_myelofibrosis_trial_101208/ 2018-07-04T15:23:22+00:00 https://www.pharmaceutical-business-review.com/news/cantex-pharmaceuticals-cx-01-gets-fda-orphan-drug-status-to-treat-acute-myeloid-leukemia-040118-6018312/ 2018-07-04T15:23:22+00:00 https://www.pharmaceutical-business-review.com/news/novaquest-capital-to-acquire-viamet-pharmaceuticals-040118-6018281/ 2018-07-04T15:23:22+00:00 https://www.pharmaceutical-business-review.com/news/momenta-mylan-to-start-trial-of-biosimilar-to-eye-drug-eylea-040118-6018292/ 2018-07-04T15:23:22+00:00 https://www.pharmaceutical-business-review.com/news/daiichi_sankyo_reports_promising_results_from_phase_ii_af_study_101208/ 2018-07-04T15:23:24+00:00 https://www.pharmaceutical-business-review.com/news/daiichi_sankyo_initiates_phase_iii_atrial_fibrillation_trial_101208/ 2018-07-04T15:23:25+00:00 https://www.pharmaceutical-business-review.com/news/asuragen_launches_new_leukemia_in_vitro_diagnostic_device_101208/ 2018-07-04T15:23:25+00:00 https://www.pharmaceutical-business-review.com/news/allos_therapeutics_presents_positive_results_from_phase_ii_lymphoma_study_101208/ 2018-07-04T15:23:25+00:00 https://www.pharmaceutical-business-review.com/news/allergans_eyelash_drug_wins_positive_recommendation_from_fda_panel_101208/ 2018-07-04T15:23:25+00:00 https://www.pharmaceutical-business-review.com/news/allergan-to-cut-over-1000-jobs-under-restructuring-program-040118-6018013/ 2018-07-04T15:23:26+00:00 https://www.pharmaceutical-business-review.com/news/centrexion-secures-funding-to-begin-trial-of-knee-osteoarthritis-pain-drug-030118-6017366/ 2018-07-04T15:23:26+00:00 https://www.pharmaceutical-business-review.com/news/pear-therapeutics-secures-50m-funding-from-temasek-030118-6016999/ 2018-07-04T15:23:26+00:00 https://www.pharmaceutical-business-review.com/news/62491intralytix_wins_new_us_patent_for_bacteriophage_trea/ 2018-07-04T15:23:27+00:00 https://www.pharmaceutical-business-review.com/news/bb4acgalapagos_signs_new_collaboration_agreements_with_dart_neurosc/ 2018-07-04T15:23:28+00:00 https://www.pharmaceutical-business-review.com/news/1948apalatin_extends_research_collaboration_with_astraz/ 2018-07-04T15:23:28+00:00 https://www.pharmaceutical-business-review.com/news/d448eroche_and_axiogenesis_sign_codevelopment_and_marketing_agre/ 2018-07-04T15:23:28+00:00 https://www.pharmaceutical-business-review.com/news/ec4a3portola_initiates_phase_ii_study_of_oral_antiplatelet/ 2018-07-04T15:23:28+00:00 https://www.pharmaceutical-business-review.com/news/recipharm-buys-remaining-stake-in-nitin-lifesciences-030118-6017035/ 2018-07-04T15:23:30+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-lymphoma-drug-adcetris-gets-priority-review-from-fda-030118-6016775/ 2018-07-04T15:23:30+00:00 https://www.pharmaceutical-business-review.com/news/atara-biotherapeutics-gets-fda-clearance-to-initiate-two-phase-3-clinical-studies-to-assess-tabelecleucel-in-patients-with-ebvptld-020118-6016426/ 2018-07-04T15:23:30+00:00 https://www.pharmaceutical-business-review.com/news/e14a5entremed_initiates_phase_i_multiple_myeloma_/ 2018-07-04T15:23:31+00:00 https://www.pharmaceutical-business-review.com/news/bd4a0stellar_signs_licensing_agreement_with_galen_for_urology_pr/ 2018-07-04T15:23:31+00:00 https://www.pharmaceutical-business-review.com/news/c0488manhattan_scientifics_announces_fda_approval_for_new_titanium_dental_im/ 2018-07-04T15:23:31+00:00 https://www.pharmaceutical-business-review.com/news/644baprometic_wins_35_million_supply_con/ 2018-07-04T15:23:32+00:00 https://www.pharmaceutical-business-review.com/news/a8489neogenix_wins_approval_for_clinical_study_of_new_diagnostic_pro/ 2018-07-04T15:23:32+00:00 https://www.pharmaceutical-business-review.com/news/study-shows-diabetes-drug-improve-memory-in-mice-with-alzheimers-disease-020118-6016148/ 2018-07-04T15:23:32+00:00 https://www.pharmaceutical-business-review.com/news/mylan-launches-estrace-cream-generic-after-fda-approval-020118-6015917/ 2018-07-04T15:23:33+00:00 https://www.pharmaceutical-business-review.com/news/ani-pharmaceuticals-buys-four-ndas-from-astrazeneca-020118-6015746/ 2018-07-04T15:23:33+00:00 https://www.pharmaceutical-business-review.com/news/symphogen_and_meiji_advance_antibody_discovery_collaboration_091208/ 2018-07-04T15:23:34+00:00 https://www.pharmaceutical-business-review.com/news/st_jude_medical_obtains_ce_mark_for_heart_device_091208/ 2018-07-04T15:23:35+00:00 https://www.pharmaceutical-business-review.com/news/silence_therapeutics_to_file_clinical_trial_application_for_cancer_drug_091208/ 2018-07-04T15:23:35+00:00 https://www.pharmaceutical-business-review.com/news/roche_wins_european_approval_for_hepatitis_drug_091208/ 2018-07-04T15:23:35+00:00 https://www.pharmaceutical-business-review.com/news/mannkinds_two_phase_iii_diabetes_trials_meet_endpoint_091208/ 2018-07-04T15:23:35+00:00 https://www.pharmaceutical-business-review.com/news/mallinckrodt-to-acquire-sucampo-pharmaceuticals-for-12bn-281217-6013713/ 2018-07-04T15:23:35+00:00 https://www.pharmaceutical-business-review.com/news/vtv-therapeutics-gives-diabetes-program-rights-in-china-to-hangzhou-zhongmei-221217-6010172/ 2018-07-04T15:23:36+00:00 https://www.pharmaceutical-business-review.com/news/roches-alecensa-secures-approval-for-alk-positive-lung-cancer-in-europe-221217-6010128/ 2018-07-04T15:23:36+00:00 https://www.pharmaceutical-business-review.com/news/summit-signs-deal-with-eurofarma-for-latin-american-rights-to-ridinilazole-221217-6010277/ 2018-07-04T15:23:38+00:00 https://www.pharmaceutical-business-review.com/news/milliporesigma-signs-commercial-supply-agreement-with-bluebird-bio-for-viral-vector-manufacturing-211217-6009909/ 2018-07-04T15:23:38+00:00 https://www.pharmaceutical-business-review.com/news/abbvies-upadacitinib-succeeds-in-phase-3-rheumatoid-arthritis-study-211217-6009502/ 2018-07-04T15:23:38+00:00 https://www.pharmaceutical-business-review.com/news/kiadis_pharma_completes_treatment_in_phase_iii_gvhd_trial_091208/ 2018-07-04T15:23:38+00:00 https://www.pharmaceutical-business-review.com/news/ista_reports_positive_phase_iii_results_for_ocular_inflammation_drug_091208/ 2018-07-04T15:23:38+00:00 https://www.pharmaceutical-business-review.com/news/cerus_wins_approval_of_expanded_label_claim_for_intercept_plasma_system_091208/ 2018-07-04T15:23:38+00:00 https://www.pharmaceutical-business-review.com/news/broncus_technologies_raises_38_million_in_series_g_financing_091208/ 2018-07-04T15:23:39+00:00 https://www.pharmaceutical-business-review.com/news/axis_shield_wins_japanese_patent_for_anti_ccp_assay_091208/ 2018-07-04T15:23:39+00:00 https://www.pharmaceutical-business-review.com/news/taris-bristol-myers-to-collaborate-on-bladder-cancer-treatment-211217-6009199/ 2018-07-04T15:23:42+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-array-biopharma-to-study-different-anti-cancer-combinations-201217-6008706/ 2018-07-04T15:23:42+00:00 https://www.pharmaceutical-business-review.com/news/evox-therapeutics-to-collaborate-with-boehringer-ingelheim-on-exosome-mediated-drug-delivery-201217-6008522/ 2018-07-04T15:23:42+00:00 https://www.pharmaceutical-business-review.com/news/avi_biopharma_files_ind_application_for_ebola_virus_study_091208/ 2018-07-04T15:23:42+00:00 https://www.pharmaceutical-business-review.com/news/auxilium_and_cpex_file_lawsuit_against_upsher_smith_laboratories_091208/ 2018-07-04T15:23:42+00:00 https://www.pharmaceutical-business-review.com/news/ambrilia_signs_license_option_agreement_with_zbx_091208/ 2018-07-04T15:23:42+00:00 https://www.pharmaceutical-business-review.com/news/alkermes_initiates_phase_i_study_of_addiction_drug_091208/ 2018-07-04T15:23:43+00:00 https://www.pharmaceutical-business-review.com/news/a4480alix_and_sosho_sign_supply_agre/ 2018-07-04T15:23:43+00:00 https://www.pharmaceutical-business-review.com/news/impax-to-sell-taiwan-manufacturing-facility-to-bora-pharmaceuticals-201217-6008467/ 2018-07-04T15:23:44+00:00 https://www.pharmaceutical-business-review.com/news/sparks-gene-therapy-luxturna-wins-fda-approval-for-rare-form-of-blindness-201217-6008241/ 2018-07-04T15:23:45+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-sanofi-submit-maa-to-ema-for-patisiran-to-treat-hereditary-amyloidosis-191217-6007236/ 2018-07-04T15:23:45+00:00 https://www.pharmaceutical-business-review.com/news/70486targanta_receives_fda_complete_response_letter_for_oritav/ 2018-07-04T15:23:46+00:00 https://www.pharmaceutical-business-review.com/news/b748croche_wins_ce_mark_for_new_hepatitis/ 2018-07-04T15:23:46+00:00 https://www.pharmaceutical-business-review.com/news/41486zymogenetics_reports_positive_results_from_phase_iiib_recothrom_/ 2018-07-04T15:23:47+00:00 https://www.pharmaceutical-business-review.com/news/e548afero_industries_signs_interim_agreement_with_pyro_pharmaceut/ 2018-07-04T15:23:47+00:00 https://www.pharmaceutical-business-review.com/news/f34a3align_technology_wins_expanded_regulatory_approval_for_invisalign_in_/ 2018-07-04T15:23:47+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-and-isa-pharmaceuticals-form-immuno-oncology-collaboration-191217-6007212/ 2018-07-04T15:23:48+00:00 https://www.pharmaceutical-business-review.com/news/allergan-gedeon-richters-bipolar-depression-drug-cariprazine-meets-primary-end-point-in-phase-3-study-191217-6007218/ 2018-07-04T15:23:48+00:00 https://www.pharmaceutical-business-review.com/news/fda-to-crackdown-on-homeopathic-drugs-marketed-with-false-claims-191217-6006910/ 2018-07-04T15:23:48+00:00 https://www.pharmaceutical-business-review.com/news/bc49eimclone_and_bristolmyers_file_sbla_for_lung_cancer/ 2018-07-04T15:23:50+00:00 https://www.pharmaceutical-business-review.com/news/a4496c_r_bard_wins_fda_approval_for_eluminexx_vascular_/ 2018-07-04T15:23:50+00:00 https://www.pharmaceutical-business-review.com/news/9b493ribx_reports_positive_topline_results_from_phase_ii_study_of_antibiotic/ 2018-07-04T15:23:51+00:00 https://www.pharmaceutical-business-review.com/news/aa4bemeda_reports_positive_results_from_phase_iii_epilepsy_/ 2018-07-04T15:23:51+00:00 https://www.pharmaceutical-business-review.com/news/874b9bioimaging_and_ag_mednet_collaborate_to_provide_imaging_sol/ 2018-07-04T15:23:51+00:00 https://www.pharmaceutical-business-review.com/news/chmp-recommends-approval-of-darvadstrocel-to-treat-complex-perianal-fistulas-in-crohns-disease-181217-6005857/ 2018-07-04T15:23:53+00:00 https://www.pharmaceutical-business-review.com/news/aclaris-therapeutics-gets-fda-nod-for-eskata-topical-solution-to-treat-raised-seborrheic-keratoses-181217-6005900/ 2018-07-04T15:23:53+00:00 https://www.pharmaceutical-business-review.com/news/mercks-keytruda-fails-to-meet-primary-endpoint-in-gastric-cancer-trial-181217-6005884/ 2018-07-04T15:23:53+00:00 https://www.pharmaceutical-business-review.com/news/7549ckiadis_pharmas_reviroc_wins_two_orphan_drug_designa/ 2018-07-04T15:23:53+00:00 https://www.pharmaceutical-business-review.com/news/6e4b1phosphagenics_reports_positive_data_from_phase_i_study_of_transdermal_lido/ 2018-07-04T15:23:54+00:00 https://www.pharmaceutical-business-review.com/news/124b1biomerieux_acquires_pml_microbiolog/ 2018-07-04T15:23:54+00:00 https://www.pharmaceutical-business-review.com/news/c04a7biowa_licenses_antibody_technology_t/ 2018-07-04T15:23:54+00:00 https://www.pharmaceutical-business-review.com/news/4f48eimmunomedics_reports_encouraging_preliminary_results_from_myeloma_/ 2018-07-04T15:23:54+00:00 https://www.pharmaceutical-business-review.com/news/cancer-research-uk-celgene-to-collaborate-on-new-anti-cancer-treatments-181217-6005642/ 2018-07-04T15:23:57+00:00 https://www.pharmaceutical-business-review.com/news/asklepios-biopharmaceutical-launches-new-portfolio-company-actus-therapeutics-151217-6003802/ 2018-07-04T15:23:57+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-pfizers-xeljanz-and-xeljanz-xr-for-treatment-of-active-psoriatic-arthritis-151217-6003657/ 2018-07-04T15:23:57+00:00 https://www.pharmaceutical-business-review.com/news/bd4bcepicept_secures_1_million_in_fina/ 2018-07-04T15:23:57+00:00 https://www.pharmaceutical-business-review.com/news/94497proteolix_presents_positive_preclinical_data_of_antitumor/ 2018-07-04T15:23:58+00:00 https://www.pharmaceutical-business-review.com/news/2548bziopharm_presents_positive_data_from_phase_ii_lymphoma_/ 2018-07-04T15:23:58+00:00 https://www.pharmaceutical-business-review.com/news/df480genomic_health_names_new_board_m/ 2018-07-04T15:23:58+00:00 https://www.pharmaceutical-business-review.com/news/0b488celgenes_combination_therapy_found_to_improve_survival_in_myeloma_/ 2018-07-04T15:23:59+00:00 https://www.pharmaceutical-business-review.com/news/israel-based-drugmaker-teva-to-cut-14000-jobs-globally-151217-6003383/ 2018-07-04T15:24:01+00:00 https://www.pharmaceutical-business-review.com/news/flexion-therapeutics-to-acquire-novel-and-non-opioid-asset-for-osteoarthritis-of-knee-141217-6002517/ 2018-07-04T15:24:02+00:00 https://www.pharmaceutical-business-review.com/news/gw-pharmaceuticals-reacquires-full-us-rights-of-sativex-141217-6002430/ 2018-07-04T15:24:02+00:00 https://www.pharmaceutical-business-review.com/news/7d4b7cydex_wins_orphan_drug_designation_for_cancer/ 2018-07-04T15:24:03+00:00 https://www.pharmaceutical-business-review.com/news/ea4a1ablynx_initiates_phase_i_study_of_antithrombotic/ 2018-07-04T15:24:03+00:00 https://www.pharmaceutical-business-review.com/news/9f490medivirs_lipsovir_maa_wins_validation_from_regulatory_author/ 2018-07-04T15:24:04+00:00 https://www.pharmaceutical-business-review.com/news/854b3inspiremd_wins_approval_in_israel_for_new_mguard_coronary_stent_s/ 2018-07-04T15:24:04+00:00 https://www.pharmaceutical-business-review.com/news/wyeth_files_marketing_authorization_application_for_pneumococcal_vaccine_081208/ 2018-07-04T15:24:04+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-remicade-biosimilar-ixifi-secures-fda-approval-141217-6002155/ 2018-07-04T15:24:05+00:00 https://www.pharmaceutical-business-review.com/news/allergan-acquires-repros-therapeutics-131217-6001267/ 2018-07-04T15:24:06+00:00 https://www.pharmaceutical-business-review.com/news/shire-gets-ec-nod-for-lyophilized-oncaspar-to-treat-acute-lymphoblastic-leukemia-131217-6001526/ 2018-07-04T15:24:06+00:00 https://www.pharmaceutical-business-review.com/news/transmolecular_reaches_agreement_with_fda_for_phase_iii_brain_tumor_study_081208/ 2018-07-04T15:24:07+00:00 https://www.pharmaceutical-business-review.com/news/pozens_pain_drug_meets_endpoint_in_phase_iii_studies_081208/ 2018-07-04T15:24:08+00:00 https://www.pharmaceutical-business-review.com/news/oncogenex_reports_positive_survival_results_from_phase_ii_cancer_trial_081208/ 2018-07-04T15:24:08+00:00 https://www.pharmaceutical-business-review.com/news/nabi_biopharmaceuticals_expands_gram_positive_patent_portfolio_081208/ 2018-07-04T15:24:08+00:00 https://www.pharmaceutical-business-review.com/news/cmc-biologics-signs-development-and-manufacturing-deal-with-harpoon-therapeutics-131217-6001227/ 2018-07-04T15:24:09+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-and-roches-venclextavenclyxto-meets-primary-endpoint-in-phase-3-rr-cll-trial-131217-6000958/ 2018-07-04T15:24:10+00:00 https://www.pharmaceutical-business-review.com/news/nih-grants-funding-for-consortium-to-advance-clinical-trials-for-alzheimers-disease-121217-6000264/ 2018-07-04T15:24:10+00:00 https://www.pharmaceutical-business-review.com/news/17494aldagen_secures_184_million_in_fina/ 2018-07-04T15:24:11+00:00 https://www.pharmaceutical-business-review.com/news/medtronic_wins_fda_approval_for_sprint_quattro_secure_defibrillation_lead_081208/ 2018-07-04T15:24:12+00:00 https://www.pharmaceutical-business-review.com/news/introgen_files_chapter_11_bankruptcy_081208/ 2018-07-04T15:24:12+00:00 https://www.pharmaceutical-business-review.com/news/intradigm_expands_rnai_therapeutics_patent_portfolio_081208/ 2018-07-04T15:24:12+00:00 https://www.pharmaceutical-business-review.com/news/ibt_laboratories_launches_two_new_assays_for_immune_deficiency_081208/ 2018-07-04T15:24:12+00:00 https://www.pharmaceutical-business-review.com/news/aeonian-pharmaceuticals-secures-funding-to-develop-mtorc1-inhibitors-121217-5999941/ 2018-07-04T15:24:13+00:00 https://www.pharmaceutical-business-review.com/news/global_meds_subsidiary_to_provide_transfusion_software_for_21_paris_hospitals_081208/ 2018-07-04T15:24:13+00:00 https://www.pharmaceutical-business-review.com/news/ardelyx-signs-license-agreement-with-fosun-pharma-for-tenapanor-in-china-121217-5999946/ 2018-07-04T15:24:14+00:00 https://www.pharmaceutical-business-review.com/news/sanofis-insulin-product-admelog-approved-by-fda-for-diabetes-121217-5999663/ 2018-07-04T15:24:14+00:00 https://www.pharmaceutical-business-review.com/news/bri_wins_fda_orphan_drug_designation_for_brain_cancer_therapy_081208/ 2018-07-04T15:24:16+00:00 https://www.pharmaceutical-business-review.com/news/avi_biopharma_files_ind_application_for_marburg_virus_study_081208/ 2018-07-04T15:24:16+00:00 https://www.pharmaceutical-business-review.com/news/alcons_ocular_hypertension_drug_wins_european_approval_081208/ 2018-07-04T15:24:17+00:00 https://www.pharmaceutical-business-review.com/news/6e4abcrucell_announces_registration_of_hepatitis_b_vaccine_in_/ 2018-07-04T15:24:17+00:00 https://www.pharmaceutical-business-review.com/news/4448bnorgine_partners_with_medical_futures_to_market_moviprep_in_c/ 2018-07-04T15:24:17+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-breast-cancer-drug-talazoparib-improves-progression-free-survival-in-phase-3-trial-111217-5999042/ 2018-07-04T15:24:18+00:00 https://www.pharmaceutical-business-review.com/news/nice-recommends-kidney-cancer-drug-lenvatinib-for-nhs-111217-5998705/ 2018-07-04T15:24:18+00:00 https://www.pharmaceutical-business-review.com/news/aerogen-pharma-lyomark-pharma-to-develop-inhaled-surfactant-111217-5998682/ 2018-07-04T15:24:18+00:00 https://www.pharmaceutical-business-review.com/news/4249eadcare_health_systems_completes_acquisition_of_van_wert_facility_in/ 2018-07-04T15:24:21+00:00 https://www.pharmaceutical-business-review.com/news/11496cfwh_opens_new_facility_in_pottstown_pennsyl/ 2018-07-04T15:24:21+00:00 https://www.pharmaceutical-business-review.com/news/9a4b7momenta_pharmaceuticals_names_new_cha/ 2018-07-04T15:24:21+00:00 https://www.pharmaceutical-business-review.com/news/1e49bcryobanks_and_dsi_sign_procurement_agreement_for_umbilical_cord_/ 2018-07-04T15:24:22+00:00 https://www.pharmaceutical-business-review.com/news/d04adnorthstar_neurosciences_cfo_re/ 2018-07-04T15:24:22+00:00 https://www.pharmaceutical-business-review.com/news/f44b4kv_pharmaceutical_announces_senior_management_ch/ 2018-07-04T15:24:26+00:00 https://www.pharmaceutical-business-review.com/news/vical_announces_restructuring_cuts_down_29_jobs_051208/ 2018-07-04T15:24:26+00:00 https://www.pharmaceutical-business-review.com/news/574a3vitrolife_wins_fda_approval_for_two_vitrification_pro/ 2018-07-04T15:24:26+00:00 https://www.pharmaceutical-business-review.com/news/41490orexigen_announces_key_management_ch/ 2018-07-04T15:24:26+00:00 https://www.pharmaceutical-business-review.com/news/biomonitor_acquires_neutekbio_051208/ 2018-07-04T15:24:27+00:00 https://www.pharmaceutical-business-review.com/news/lillys-cyramza-meets-primary-objective-in-phase-3-gastric-cancer-trial-111217-5998408/ 2018-07-04T15:24:29+00:00 https://www.pharmaceutical-business-review.com/news/roches-tecentriq-plus-chemotherapy-reduces-disease-progression-in-lung-cancer-study-081217-5997567/ 2018-07-04T15:24:29+00:00 https://www.pharmaceutical-business-review.com/news/global-cryotherapy-market-expected-to-exceed-us-4-billion-by-2024-persistence-market-research-081217-5997303/ 2018-07-04T15:24:29+00:00 https://www.pharmaceutical-business-review.com/news/nps_pharmaceuticals_initiates_enrollment_in_phase_iii_sbs_trial_051208/ 2018-07-04T15:24:30+00:00 https://www.pharmaceutical-business-review.com/news/generex_reports_positive_results_from_metformin_chewing_gum_trial_051208/ 2018-07-04T15:24:30+00:00 https://www.pharmaceutical-business-review.com/news/morphotek_initiates_phase_ii_ovarian_cancer_study_051208/ 2018-07-04T15:24:31+00:00 https://www.pharmaceutical-business-review.com/news/9c485lentigen_and_path_form_partne/ 2018-07-04T15:24:31+00:00 https://www.pharmaceutical-business-review.com/news/ff495delcath_systemss_director_re/ 2018-07-04T15:24:31+00:00 https://www.pharmaceutical-business-review.com/news/bluebird-bio-tc-biopharm-to-develop-gamma-delta-car-t-cell-product-candidates-for-cancer-immunotherapy-081217-5997323/ 2018-07-04T15:24:32+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-to-acquire-cell-design-labs-in-567m-deal-081217-5997070/ 2018-07-04T15:24:32+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-invest-40m-in-genetic-research-under-uk-sector-deal-071217-5996267/ 2018-07-04T15:24:33+00:00 https://www.pharmaceutical-business-review.com/news/934b0sanofi_to_axe_us_sales/ 2018-07-04T15:24:34+00:00 https://www.pharmaceutical-business-review.com/news/1f4abzeltia_files_application_for_european_approval_of_ovarian_cancer/ 2018-07-04T15:24:34+00:00 https://www.pharmaceutical-business-review.com/news/724aboctapharma_names_new_president_of_us_subsi/ 2018-07-04T15:24:34+00:00 https://www.pharmaceutical-business-review.com/news/ea494transgenomic_acquires_license_to_mtdna_damage_detection_techn/ 2018-07-04T15:24:34+00:00 https://www.pharmaceutical-business-review.com/news/69496middlebrook_opens_new_administrative_and_sales_office_in_/ 2018-07-04T15:24:35+00:00 https://www.pharmaceutical-business-review.com/news/fate-therapeutics-university-of-california-san-diego-to-develop-ipsc-derived-car-nk-cell-cancer-immunotherapies-071217-5996156/ 2018-07-04T15:24:36+00:00 https://www.pharmaceutical-business-review.com/news/carmot-amgen-form-drug-discovery-partnership-071217-5996053/ 2018-07-04T15:24:36+00:00 https://www.pharmaceutical-business-review.com/news/novartis-breast-cancer-drug-kisqali-increases-survival-of-premenopausal-women-071217-5995852/ 2018-07-04T15:24:36+00:00 https://www.pharmaceutical-business-review.com/news/0d4bbperrigo_resolves_desloratadine_tablets_patent_litig/ 2018-07-04T15:24:38+00:00 https://www.pharmaceutical-business-review.com/news/13482genta_wins_fda_orphan_drug_designation_for_melanoma/ 2018-07-04T15:24:38+00:00 https://www.pharmaceutical-business-review.com/news/a148echina_sky_one_medical_wins_production_approval_for_new_nasal_drop_in_/ 2018-07-04T15:24:38+00:00 https://www.pharmaceutical-business-review.com/news/304bcpdl_biopharma_names_new_director_of_facet_bi/ 2018-07-04T15:24:39+00:00 https://www.pharmaceutical-business-review.com/news/ae4a1osiris_completes_enrollment_in_phase_iii_gvhd_/ 2018-07-04T15:24:39+00:00 https://www.pharmaceutical-business-review.com/news/janssens-imbruvica-rituximab-combination-meets-primary-end-point-in-phase-3-study-061217-5995014/ 2018-07-04T15:24:40+00:00 https://www.pharmaceutical-business-review.com/news/arena-everest-medicines-form-partnership-for-ralinepag-and-etrasimod-in-china-061217-5994796/ 2018-07-04T15:24:40+00:00 https://www.pharmaceutical-business-review.com/news/realm-therapeutics-doses-first-patient-in-phase-2-study-of-pr022-to-treat-atopic-dermatitis-061217-5994848/ 2018-07-04T15:24:40+00:00 https://www.pharmaceutical-business-review.com/news/f44aahemispherx_biopharma_names_ne/ 2018-07-04T15:24:42+00:00 https://www.pharmaceutical-business-review.com/news/0b4b9urovalve_initiates_enrollment_for_surinate_urinary_catheter_/ 2018-07-04T15:24:42+00:00 https://www.pharmaceutical-business-review.com/news/ba4b8pra_international_opens_new_office_in_munich_ge/ 2018-07-04T15:24:42+00:00 https://www.pharmaceutical-business-review.com/news/fc49dventirx_initiates_phase_i_cancer_/ 2018-07-04T15:24:43+00:00 https://www.pharmaceutical-business-review.com/news/7849cmillipore_signs_licensing_agreement_with_ast/ 2018-07-04T15:24:43+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisks-diabetic-drug-ozempic-secures-fda-approval-061217-5994434/ 2018-07-04T15:24:44+00:00 https://www.pharmaceutical-business-review.com/news/researchers-show-aspirin-added-to-cancer-drug-improves-effectiveness-051217-5993594/ 2018-07-04T15:24:44+00:00 https://www.pharmaceutical-business-review.com/news/blue-oak-psychogenics-enter-into-drug-discovery-partnership-051217-5993531/ 2018-07-04T15:24:44+00:00 https://www.pharmaceutical-business-review.com/news/214a8accuray_names_ne/ 2018-07-04T15:24:45+00:00 https://www.pharmaceutical-business-review.com/news/0c49bparions_partner_gilead_initiates_phase_i_pulmonary_disease_/ 2018-07-04T15:24:45+00:00 https://www.pharmaceutical-business-review.com/news/23494azur_pharma_acquires_us_rights_to_biosantes_menopause/ 2018-07-04T15:24:46+00:00 https://www.pharmaceutical-business-review.com/news/88483fibrogen_names_new_vice_president_of_clinical_develo/ 2018-07-04T15:24:46+00:00 https://www.pharmaceutical-business-review.com/news/e14bcmedimmune_initiates_phase_ii_asthma_/ 2018-07-04T15:24:46+00:00 https://www.pharmaceutical-business-review.com/news/abbvies-risankizumab-meets-all-primary-endpoints-in-fourth-phase-3-psoriasis-trial-041217-5993270/ 2018-07-04T15:24:47+00:00 https://www.pharmaceutical-business-review.com/news/astellas-pharma-acquires-mitobridge-for-225m-041217-5992367/ 2018-07-04T15:24:48+00:00 https://www.pharmaceutical-business-review.com/news/i-mab-biopharma-partners-with-morphosys-on-cancer-investigational-medicine-041217-5992372/ 2018-07-04T15:24:48+00:00 https://www.pharmaceutical-business-review.com/news/664bebd_wins_fda_approval_for_focalpoint_gs_imaging_s/ 2018-07-04T15:24:49+00:00 https://www.pharmaceutical-business-review.com/news/ed482opko_health_completes_enrollment_in_phase_iii_wet_amd_/ 2018-07-04T15:24:49+00:00 https://www.pharmaceutical-business-review.com/news/304b1novarx_names_new_president_an/ 2018-07-04T15:24:49+00:00 https://www.pharmaceutical-business-review.com/news/1e4b4mediwares_subsidiary_wins_new_south_african_contract_for_pharmacy_sof/ 2018-07-04T15:24:50+00:00 https://www.pharmaceutical-business-review.com/news/3d4bbvical_licenses_melanoma_drug_to_eczacibasi_ilac_paza/ 2018-07-04T15:24:50+00:00 https://www.pharmaceutical-business-review.com/news/amgens-repatha-approved-by-fda-for-heart-attack-and-stroke-prevention-041217-5992264/ 2018-07-04T15:24:50+00:00 https://www.pharmaceutical-business-review.com/news/restorbio-secures-40m-funding-to-advance-selective-torc1-inhibitors-011217-5991222/ 2018-07-04T15:24:51+00:00 https://www.pharmaceutical-business-review.com/news/nih-and-partners-commence-hiv-vaccine-efficacy-study-011217-5991212/ 2018-07-04T15:24:51+00:00 https://www.pharmaceutical-business-review.com/news/2149agerons_partner_merck_initiates_phase_i_study_of_cancer_va/ 2018-07-04T15:24:52+00:00 https://www.pharmaceutical-business-review.com/news/54491aeterna_zentaris_completes_sale_of_cetrotide_royalty_stream_to/ 2018-07-04T15:24:52+00:00 https://www.pharmaceutical-business-review.com/news/234b4polymedix_names_new_vice_president_of_business_develo/ 2018-07-04T15:24:52+00:00 https://www.pharmaceutical-business-review.com/news/c54basorin_group_divests_vascular_therapy_business/ 2018-07-04T15:24:53+00:00 https://www.pharmaceutical-business-review.com/news/124acupshersmith_laboratories_launches_prenatal_vitamin_ca/ 2018-07-04T15:24:53+00:00 https://www.pharmaceutical-business-review.com/news/indivior-secures-fda-approval-for-sublocade-for-opioid-use-disorder-011217-5990981/ 2018-07-04T15:24:53+00:00 https://www.pharmaceutical-business-review.com/news/revance-to-advance-cervical-dystonia-drug-into-phase-3-program-301117-5990012/ 2018-07-04T15:24:54+00:00 https://www.pharmaceutical-business-review.com/news/melinta-therapeutics-to-buy-infectious-disease-business-from-the-medicines-company-301117-5990251/ 2018-07-04T15:24:54+00:00 https://www.pharmaceutical-business-review.com/news/5d4bepharmaengine_wins_approval_for_phase_ii_pancreatic_cancer_/ 2018-07-04T15:24:55+00:00 https://www.pharmaceutical-business-review.com/news/takedas_gout_drug_wins_positive_recommendation_from_fda_panel_041208/ 2018-07-04T15:24:55+00:00 https://www.pharmaceutical-business-review.com/news/scinopharm_wins_new_us_patent_for_crystal_forms_of_oncology_product_041208/ 2018-07-04T15:24:56+00:00 https://www.pharmaceutical-business-review.com/news/torreypiness_pain_drug_meets_study_endpoints_041208/ 2018-07-04T15:24:56+00:00 https://www.pharmaceutical-business-review.com/news/medicis_and_impax_sign_rd_collaboration_and_settlement_agreement_041208/ 2018-07-04T15:24:56+00:00 https://www.pharmaceutical-business-review.com/news/novartis-amgens-erenumab-succeeds-in-phase-3-episodic-migraine-trial-301117-5989849/ 2018-07-04T15:24:57+00:00 https://www.pharmaceutical-business-review.com/news/vikings-hip-fracture-treatment-vk5211-meets-primary-endpoint-in-phase-2-study-291117-5989285/ 2018-07-04T15:24:57+00:00 https://www.pharmaceutical-business-review.com/news/titan-grants-european-marketing-rights-of-probuphine-to-molteni-291117-5988739/ 2018-07-04T15:24:57+00:00 https://www.pharmaceutical-business-review.com/news/marshall_edwards_files_ind_application_for_oncology_drug_041208/ 2018-07-04T15:24:59+00:00 https://www.pharmaceutical-business-review.com/news/geovax_to_initiate_phase_iia_hiv_vaccine_trials_041208/ 2018-07-04T15:24:59+00:00 https://www.pharmaceutical-business-review.com/news/genaera_initiates_dosing_in_phase_ib_study_of_diabetes_and_obesity_drug_041208/ 2018-07-04T15:24:59+00:00 https://www.pharmaceutical-business-review.com/news/flexicath_raises_600000_in_financing_wins_clearance_for_new_catheter_041208/ 2018-07-04T15:25:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-starts-phase-1-trial-of-zika-virus-vaccine-candidate-291117-5988486/ 2018-07-04T15:25:00+00:00 https://www.pharmaceutical-business-review.com/news/biothera-pharmaceuticals-enters-cancer-immunotherapy-clinical-trial-collaboration-agreement-291117-5988905/ 2018-07-04T15:25:00+00:00 https://www.pharmaceutical-business-review.com/news/regenerons-eye-drug-combination-is-not-effective-in-two-phase-2-studies-281117-5987949/ 2018-07-04T15:25:00+00:00 https://www.pharmaceutical-business-review.com/news/eu_accuses_pharma_companies_of_adopting_anti_competitive_practices_041208/ 2018-07-04T15:25:03+00:00 https://www.pharmaceutical-business-review.com/news/dor_biopharma_receives_15_million_from_sigma_tau_pharmaceuticals_041208/ 2018-07-04T15:25:03+00:00 https://www.pharmaceutical-business-review.com/news/viiv-healthcare-begins-third-phase-iii-hiv-trial-of-cabotegravirrilpivirine-regimen-281117-5987739/ 2018-07-04T15:25:03+00:00 https://www.pharmaceutical-business-review.com/news/biogen-alkermes-to-develop-and-commercialize-alks-8700-to-treat-multiple-sclerosis-281117-5987717/ 2018-07-04T15:25:03+00:00 https://www.pharmaceutical-business-review.com/news/msd-to-establish-discovery-research-center-in-london-281117-5987428/ 2018-07-04T15:25:03+00:00 https://www.pharmaceutical-business-review.com/news/cell_therapeuticss_zevalin_sbla_wins_fda_priority_review_041208/ 2018-07-04T15:25:04+00:00 https://www.pharmaceutical-business-review.com/news/cardinal_health_and_sri_surgical_sign_supply_agreement_for_surgical_kits_041208/ 2018-07-04T15:25:04+00:00 https://www.pharmaceutical-business-review.com/news/ark_files_marketing_authorization_application_for_cancer_drug_041208/ 2018-07-04T15:25:04+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-submits-snda-for-tagriss-to-treat-egfrm-nsclc-271117-5986833/ 2018-07-04T15:25:06+00:00 https://www.pharmaceutical-business-review.com/news/pharming-submits-supplemental-bla-to-fda-for-ruconest-for-prophylaxis-of-hereditary-angioedema-attacks-271117-5986672/ 2018-07-04T15:25:07+00:00 https://www.pharmaceutical-business-review.com/news/sun-pharma-recalls-diabetes-medicine-over-microbial-contamination-271117-5986453/ 2018-07-04T15:25:07+00:00 https://www.pharmaceutical-business-review.com/news/advanced_cell_technology_and_cha_biotech_form_new_jv_041208/ 2018-07-04T15:25:08+00:00 https://www.pharmaceutical-business-review.com/news/fc49dadvanced_life_sciences_files_nda_for_pneumonia/ 2018-07-04T15:25:08+00:00 https://www.pharmaceutical-business-review.com/news/7948cconjuchem_and_novozymes_sign_manufacturing_and_supply_agre/ 2018-07-04T15:25:08+00:00 https://www.pharmaceutical-business-review.com/news/21490dxterity_and_city_of_hope_form_therapeutics_collabor/ 2018-07-04T15:25:09+00:00 https://www.pharmaceutical-business-review.com/news/d3492lescarden_signs_distribution_agreement_with_cranage_healt/ 2018-07-04T15:25:09+00:00 https://www.pharmaceutical-business-review.com/news/kmt-hepatech-secures-investment-from-phoenixbio-241117-5985661/ 2018-07-04T15:25:10+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-tremfya-to-treat-moderate-to-severe-plaque-psoriasis-241117-5985676/ 2018-07-04T15:25:10+00:00 https://www.pharmaceutical-business-review.com/news/uk-researchers-seek-improved-treatment-for-head-and-neck-cancer-241117-5985423/ 2018-07-04T15:25:10+00:00 https://www.pharmaceutical-business-review.com/news/cytokinetics-als-treatment-tirasemtiv-fails-to-meet-primary-endpoint-in-phase-3-study-231117-5984712/ 2018-07-04T15:25:12+00:00 https://www.pharmaceutical-business-review.com/news/midatech-secures-manufacturing-certification-from-regulatory-authority-231117-5984634/ 2018-07-04T15:25:13+00:00 https://www.pharmaceutical-business-review.com/news/uk-researchers-say-gastric-acid-suppressant-lansoprazole-could-treat-tb-231117-5984454/ 2018-07-04T15:25:13+00:00 https://www.pharmaceutical-business-review.com/news/european-prevention-of-alzheimers-dementia-consortium-opens-six-new-study-sites-5986586/ 2018-07-04T15:25:16+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-viiv-healthcares-two-drug-regimen-to-treat-hiv-1-infection-221117-5983707/ 2018-07-04T15:25:16+00:00 https://www.pharmaceutical-business-review.com/news/fresenius-kabi-to-expand-pharmaceutical-manufacturing-in-north-carolina-221017-5983373/ 2018-07-04T15:25:17+00:00 https://www.pharmaceutical-business-review.com/news/uk-competition-regulator-accuses-concordia-of-unfair-pricing-of-thyroid-drug-221117-5983130/ 2018-07-04T15:25:20+00:00 https://www.pharmaceutical-business-review.com/news/janssen-seeks-ema-approval-for-darzalex-for-newly-diagnosed-multiple-myeloma-221117-5983357/ 2018-07-04T15:25:20+00:00 https://www.pharmaceutical-business-review.com/news/novartis-gets-ec-approval-for-tasign-to-treat-ph-cml-cp-in-children-211117-5982795/ 2018-07-04T15:25:21+00:00 https://www.pharmaceutical-business-review.com/news/hemogenyx-university-of-oxford-to-collaborate-on-blood-stem-cell-research-211117-5982239/ 2018-07-04T15:25:24+00:00 https://www.pharmaceutical-business-review.com/news/mpa-advice-on-oxpzero-ibuprofen-otc-opportunity-211117-5982181/ 2018-07-04T15:25:24+00:00 https://www.pharmaceutical-business-review.com/news/summits-dmd-phase-2-trial-for-ezutromid-completes-half-way-stage-211117-5982037/ 2018-07-04T15:25:25+00:00 https://www.pharmaceutical-business-review.com/news/canadian-researchers-discover-medication-to-treat-amyotrophic-lateral-sclerosis-201117-5981446/ 2018-07-04T15:25:27+00:00 https://www.pharmaceutical-business-review.com/news/can-fites-ex-subsidiary-ophthalix-merges-with-wize-pharma-201117-5981120/ 2018-07-04T15:25:27+00:00 https://www.pharmaceutical-business-review.com/news/cerecor-acquires-trx-pharmaceuticals-201117-5981084/ 2018-07-04T15:25:28+00:00 https://www.pharmaceutical-business-review.com/news/samsung-bioepis-trastuzumab-biosimilar-gets-ec-approval-for-breast-cancer-201117-5980832/ 2018-07-04T15:25:30+00:00 https://www.pharmaceutical-business-review.com/news/cue-biopharma-merck-form-research-collaboration-for-treating-autoimmune-disease-171117-5974154/ 2018-07-04T15:25:30+00:00 https://www.pharmaceutical-business-review.com/news/ionis-licenses-antisense-drug-to-janssen-171117-5974141/ 2018-07-04T15:25:30+00:00 https://www.pharmaceutical-business-review.com/news/roches-hemlibra-bags-fda-approval-for-hemophilia-a-with-inhibitors-171117-5974128/ 2018-07-04T15:25:33+00:00 https://www.pharmaceutical-business-review.com/news/inozyme-pharma-bags-49m-funding-for-rare-disease-therapies-161117-5973231/ 2018-07-04T15:25:33+00:00 https://www.pharmaceutical-business-review.com/news/arvinas-genentech-expand-license-agreement-for-protac-161117-5973219/ 2018-07-04T15:25:34+00:00 https://www.pharmaceutical-business-review.com/news/ultragenyxs-mepsevii-secures-fda-approval-for-mucopolysaccharidosis-vii-161117-5972999/ 2018-07-04T15:25:35+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-gets-fda-nod-for-fasenra-to-treat-severe-eosinophilic-asthma-151117-5972468/ 2018-07-04T15:25:36+00:00 https://www.pharmaceutical-business-review.com/news/purdue-pharma-to-invest-in-oncology-research-and-development-5972200/ 2018-07-04T15:25:36+00:00 https://www.pharmaceutical-business-review.com/news/cardinal-to-divest-drug-distribution-business-in-china-to-shanghai-pharma-151117-5972079/ 2018-07-04T15:25:38+00:00 https://www.pharmaceutical-business-review.com/news/bayer-and-loxo-oncology-to-develop-and-commercialize-two-cancer-therapies-151117-5972167/ 2018-07-04T15:25:38+00:00 https://www.pharmaceutical-business-review.com/news/arcus-biosciences-secures-funding-to-advance-clinical-programs-for-ab928-141117-5971095/ 2018-07-04T15:25:38+00:00 https://www.pharmaceutical-business-review.com/news/sumitomo-to-buy-20-stake-in-sawai-america-for-211m-141117-5971076/ 2018-07-04T15:25:41+00:00 https://www.pharmaceutical-business-review.com/news/ema-grants-prime-designation-for-mereos-bps-804-to-treat-osteogenesis-imperfecta-141117-5971063/ 2018-07-04T15:25:42+00:00 https://www.pharmaceutical-business-review.com/news/otsuka-secures-fda-approval-for-antipsychotic-digital-medicine-abilify-mycite-141117-5970849/ 2018-07-04T15:25:42+00:00 https://www.pharmaceutical-business-review.com/news/fda-expands-approval-of-bristol-myers-squibbs-sprycel-to-include-pediatric-patients-13117-5970162/ 2018-07-04T15:25:45+00:00 https://www.pharmaceutical-business-review.com/news/research-suggests-potential-treatment-for-autism-and-intellectual-disability-131117-5970138/ 2018-07-04T15:25:45+00:00 https://www.pharmaceutical-business-review.com/news/emas-chmp-recommends-amgen-annd-allergans-abp-215-to-treat-certain-types-of-cancer-131117-5970135/ 2018-07-04T15:25:45+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-to-exit-from-chinese-generic-drug-joint-venture-with-hisun-131117-5969914/ 2018-07-04T15:25:49+00:00 https://www.pharmaceutical-business-review.com/news/merck-gets-fda-approval-for-prevymis-to-prevent-cmv-infection-and-disease-in-adult-allogeneic-stem-cell-transplant-patients-101117-5969106/ 2018-07-04T15:25:49+00:00 https://www.pharmaceutical-business-review.com/news/sages-brexanolone-meets-primary-endpoints-in-phase-3-postpartum-depression-trials-101117-5969028/ 2018-07-04T15:25:49+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-to-develop-principias-multiple-sclerosis-drug-candidate-5968854/ 2018-07-04T15:25:51+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-mina-therapeutics-partner-to-develop-novel-treatments-for-fibrotic-liver-diseases-091117-5968254/ 2018-07-04T15:25:51+00:00 https://www.pharmaceutical-business-review.com/news/cerenis-therapeutics-acquires-lypro-biosciences-091117-5968063/ 2018-07-04T15:25:52+00:00 https://www.pharmaceutical-business-review.com/news/tricida-announces-closing-of-575m-series-d-financing-091117-5968094/ 2018-07-04T15:25:54+00:00 https://www.pharmaceutical-business-review.com/news/novartis-breast-cancer-drug-kisqali-succeeds-in-phase-3-study-in-premenopausal-women-091117-5967811/ 2018-07-04T15:25:55+00:00 https://www.pharmaceutical-business-review.com/news/new-consortium-to-enhance-discovery-of-novel-drugs-for-kidney-diseases-081117-5967213/ 2018-07-04T15:25:55+00:00 https://www.pharmaceutical-business-review.com/news/spark-therapeutics-pfizer-amend-license-agreement-for-investigational-spk-9001-in-hemophilia-b-081117-5967001/ 2018-07-04T15:25:58+00:00 https://www.pharmaceutical-business-review.com/news/roche-secures-fda-approvals-for-cancer-drugs-zelboraf-and-alecensa-081117-5966747/ 2018-07-04T15:25:58+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-says-biosimilar-cyltezo-efficacy-and-safety-on-par-with-humira-071117-5965867/ 2018-07-04T15:26:01+00:00 https://www.pharmaceutical-business-review.com/news/fda-lifts-clinical-hold-on-cellectis-phase-1-clinical-trials-with-ucart123-in-aml-and-bpdcn-071117-5966074/ 2018-07-04T15:26:01+00:00 https://www.pharmaceutical-business-review.com/news/284absirslab_wins_ce_mark_for_new_sepsis/ 2018-07-04T15:26:02+00:00 https://www.pharmaceutical-business-review.com/news/4a4b6bausch__lomb_names_new_corporate_vice_pres/ 2018-07-04T15:26:02+00:00 https://www.pharmaceutical-business-review.com/news/novartis-seeks-ema-approval-for-blood-cancer-drug-kymriah-071117-5965958/ 2018-07-04T15:26:02+00:00 https://www.pharmaceutical-business-review.com/news/3e4abseegene_wins_canadian_approval_for_virus_detection_te/ 2018-07-04T15:26:02+00:00 https://www.pharmaceutical-business-review.com/news/9749dcellectricon_and_tap_sign_collaboration_agreem/ 2018-07-04T15:26:03+00:00 https://www.pharmaceutical-business-review.com/news/174a3cell_genesys_and_takeda_terminate_collaboration_agreem/ 2018-07-04T15:26:03+00:00 https://www.pharmaceutical-business-review.com/news/valeant-to-divest-libido-pill-business-sprout-to-former-owners-071117-5965678/ 2018-07-04T15:26:04+00:00 https://www.pharmaceutical-business-review.com/news/torrent-to-acquire-branded-business-of-india-and-nepal-from-unichem-061117-5964910/ 2018-07-04T15:26:04+00:00 https://www.pharmaceutical-business-review.com/news/6a488nymox_reports_new_positive_data_from_bph_/ 2018-07-04T15:26:05+00:00 https://www.pharmaceutical-business-review.com/news/celonic-acquires-glycotopes-bio-manufacturing-plant-in-germany-061117-5964796/ 2018-07-04T15:26:05+00:00 https://www.pharmaceutical-business-review.com/news/a249danika_completes_enrollment_for_osteoarthritis_/ 2018-07-04T15:26:06+00:00 https://www.pharmaceutical-business-review.com/news/diadexus_wins_ce_mark_for_plac_test_041208/ 2018-07-04T15:26:06+00:00 https://www.pharmaceutical-business-review.com/news/fc49cev3_names_new_board_m/ 2018-07-04T15:26:06+00:00 https://www.pharmaceutical-business-review.com/news/c2482nps_pharmaceuticals_names_new_chief_medical_of/ 2018-07-04T15:26:06+00:00 https://www.pharmaceutical-business-review.com/news/scientists-say-blood-plasma-infusions-could-possibly-treat-alzheimers-061117-5964559/ 2018-07-04T15:26:07+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-alnylam-present-positive-complete-results-of-patisiran-from-phase-3-study-in-hattr-amyloidosis-patients-with-polyneuropathy-031117-5963836/ 2018-07-04T15:26:07+00:00 https://www.pharmaceutical-business-review.com/news/xenetic-baxalta-sign-sublicense-agreement-for-polyxen-technology-110317-5963772/ 2018-07-04T15:26:07+00:00 https://www.pharmaceutical-business-review.com/news/8049dmaas_biolab_enters_phase_ii_for_development_of_als/ 2018-07-04T15:26:09+00:00 https://www.pharmaceutical-business-review.com/news/67485evotec_and_novartis_form_drug_discovery_collabor/ 2018-07-04T15:26:09+00:00 https://www.pharmaceutical-business-review.com/news/2849ecatalyst_biosciences_raises_404_million_in_series_c_fina/ 2018-07-04T15:26:09+00:00 https://www.pharmaceutical-business-review.com/news/084aftibotec_signs_licensing_agreement_with_emcure_pharmaceut/ 2018-07-04T15:26:09+00:00 https://www.pharmaceutical-business-review.com/news/394aaaga_medical_wins_ce_mark_for_amplatzer_cardiac/ 2018-07-04T15:26:10+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-dicerna-to-collaborate-on-rnai-therapeutics-for-liver-diseases-031117-5963463/ 2018-07-04T15:26:10+00:00 https://www.pharmaceutical-business-review.com/news/gsks-study-shows-anoro-ellipta-improves-lung-function-in-copd-patients-021117-5962920/ 2018-07-04T15:26:10+00:00 https://www.pharmaceutical-business-review.com/news/novartis-submits-sbla-for-lymphoma-drug-kymriah-to-fda-021117-5962754/ 2018-07-04T15:26:11+00:00 https://www.pharmaceutical-business-review.com/news/a7490astrazeneca_names_new_cfo_of_north_american_opera/ 2018-07-04T15:26:12+00:00 https://www.pharmaceutical-business-review.com/news/024b7sigmaaldrich_signs_distribution_agreement_with_southwest_nanotechnol/ 2018-07-04T15:26:12+00:00 https://www.pharmaceutical-business-review.com/news/e04b3xenoports_acid_reflux_drug_fails_end/ 2018-07-04T15:26:12+00:00 https://www.pharmaceutical-business-review.com/news/4149dhorizon_therapeuticss_phase_iii_painrelief_trials_meet_end/ 2018-07-04T15:26:13+00:00 https://www.pharmaceutical-business-review.com/news/634a9neurogen_announces_termination_of_facilities_sale_agre/ 2018-07-04T15:26:13+00:00 https://www.pharmaceutical-business-review.com/news/fda-advisory-committees-recommend-approval-of-indiviors-rbp-6000-to-treat-opioid-use-disorder-021117-5962741/ 2018-07-04T15:26:14+00:00 https://www.pharmaceutical-business-review.com/news/abbvies-endometriosis-drug-elagolix-yields-positive-results-in-phase-3-extension-studies-021117-5962422/ 2018-07-04T15:26:14+00:00 https://www.pharmaceutical-business-review.com/news/kirin-to-receive-780m-to-exit-from-kirin-amgen-jv-011117-5961808/ 2018-07-04T15:26:14+00:00 https://www.pharmaceutical-business-review.com/news/7d48dbiotronik_announces_enrollment_of_european_patients_in_heart_failure_/ 2018-07-04T15:26:17+00:00 https://www.pharmaceutical-business-review.com/news/a4499medtronic_introduces_new_sprinter_angioplasty_balloon_cath/ 2018-07-04T15:26:17+00:00 https://www.pharmaceutical-business-review.com/news/e54aebioelectronics_reports_positive_results_from_breast_augmentation_recovery_/ 2018-07-04T15:26:17+00:00 https://www.pharmaceutical-business-review.com/news/aviragen-therapeutics-announces-merger-with-vaxart-011117-5961620/ 2018-07-04T15:26:17+00:00 https://www.pharmaceutical-business-review.com/news/voyager-to-receive-worldwide-rights-to-vy-aadc-program-for-advanced-parkinsons-disease-011117-5961604/ 2018-07-04T15:26:17+00:00 https://www.pharmaceutical-business-review.com/news/e44a0questcor_resubmits_snda_for_infantile_spasm/ 2018-07-04T15:26:18+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-astrazenecas-calquence-for-mantle-cell-lymphoma-011117-5961302/ 2018-07-04T15:26:18+00:00 https://www.pharmaceutical-business-review.com/news/pharmacyclics_completes_phase_i_study_of_factor_viia_inhibitor_031208/ 2018-07-04T15:26:20+00:00 https://www.pharmaceutical-business-review.com/news/morphosys_to_receive_us_patent_for_key_antibody_031208/ 2018-07-04T15:26:21+00:00 https://www.pharmaceutical-business-review.com/news/king_pharmaceuticals_to_buy_alpharma_for_16_billion_031208/ 2018-07-04T15:26:21+00:00 https://www.pharmaceutical-business-review.com/news/janssens-xarelto-secures-fda-approval-for-venous-thromboembolism-3110117-5960559/ 2018-07-04T15:26:21+00:00 https://www.pharmaceutical-business-review.com/news/lannett-celgene-sign-settlement-and-license-agreement-related-to-thalomid-311017-5960581/ 2018-07-04T15:26:21+00:00 https://www.pharmaceutical-business-review.com/news/jj_to_acquire_omrix_biopharmaceuticals_for_438_million_031208/ 2018-07-04T15:26:22+00:00 https://www.pharmaceutical-business-review.com/news/galapagos_and_morphosys_join_hands_in_antibody_drug_development_program_031208/ 2018-07-04T15:26:22+00:00 https://www.pharmaceutical-business-review.com/news/novartis-to-buy-nuclear-medicine-firm-advanced-accelerator-applications-for-39bn-311017-5960315/ 2018-07-04T15:26:22+00:00 https://www.pharmaceutical-business-review.com/news/abbvies-psoriasis-drug-risankizumab-shows-significant-effect-in-three-phase-3-clinical-trials-301017-5959641/ 2018-07-04T15:26:24+00:00 https://www.pharmaceutical-business-review.com/news/novartis-reports-significant-results-of-gilenyas-clinical-trial-for-pediatric-multiple-sclerosis-301017-5959583/ 2018-07-04T15:26:25+00:00 https://www.pharmaceutical-business-review.com/news/merck-withdraws-european-application-for-keytruda-combination-for-nsclc-301017-5959372/ 2018-07-04T15:26:25+00:00 https://www.pharmaceutical-business-review.com/news/exelixis_and_bristol_myers_squibb_to_co_develop_new_cancer_drug_031208/ 2018-07-04T15:26:26+00:00 https://www.pharmaceutical-business-review.com/news/cephalon_signs_option_agreement_with_immupharma_for_lupus_drug_031208/ 2018-07-04T15:26:26+00:00 https://www.pharmaceutical-business-review.com/news/paladin_labs_signs_agreement_with_gsk_for_adhd_drug_031208/ 2018-07-04T15:26:27+00:00 https://www.pharmaceutical-business-review.com/news/cambridge_laboratories_announces_launch_of_huntingtons_drug_in_us_031208/ 2018-07-04T15:26:27+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-roches-sbla-for-avastin-to-treat-women-with-advanced-ovarian-cancer-271017-5958548/ 2018-07-04T15:26:27+00:00 https://www.pharmaceutical-business-review.com/news/oncoquest-to-collaborate-with-tesaro-in-recurrent-ovarian-cancer-setting-271017-5958508/ 2018-07-04T15:26:28+00:00 https://www.pharmaceutical-business-review.com/news/auxilium_and_ferring_sign_licensing_agreement_for_testosterone_gel_031208/ 2018-07-04T15:26:29+00:00 https://www.pharmaceutical-business-review.com/news/anika_terminates_us_distribution_contract_with_artes_medical_031208/ 2018-07-04T15:26:30+00:00 https://www.pharmaceutical-business-review.com/news/akorn_signs_mou_with_bioluz_for_five_premix_products_031208/ 2018-07-04T15:26:30+00:00 https://www.pharmaceutical-business-review.com/news/tgen-ucsf-study-uses-genomics-to-make-treatment-recommendations-for-recurrent-glioblastoma-patients-5956945/ 2018-07-04T15:26:31+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-to-invest-100m-in-irish-facility-to-increase-drug-production-271017-5958295/ 2018-07-04T15:26:32+00:00 https://www.pharmaceutical-business-review.com/news/breast-cancer-study-identifies-new-genetic-variants-behind-disease-261017-5957303/ 2018-07-04T15:26:32+00:00 https://www.pharmaceutical-business-review.com/news/9b4a2eisai_to_initiate_comparator_study_of_hypomethylating_/ 2018-07-04T15:26:34+00:00 https://www.pharmaceutical-business-review.com/news/59498circulite_names_ne/ 2018-07-04T15:26:35+00:00 https://www.pharmaceutical-business-review.com/news/484abneuralstem_partners_with_hospital_of_taiwan_to_develop_stem_cell_ther/ 2018-07-04T15:26:35+00:00 https://www.pharmaceutical-business-review.com/news/a349badeona_and_nnri_form_research_collaboration_to_evaluate_ophthalmic/ 2018-07-04T15:26:35+00:00 https://www.pharmaceutical-business-review.com/news/8e4a2china_sky_one_medical_names_ne/ 2018-07-04T15:26:35+00:00 https://www.pharmaceutical-business-review.com/news/incyte-macrogenics-sign-licensing-agreement-for-anti-pd-1-monoclonal-antibody-mga012-261017-5957305/ 2018-07-04T15:26:36+00:00 https://www.pharmaceutical-business-review.com/news/fda-rejects-approval-of-ptc-therapeutics-dmd-drug-ataluren-261017-5957082/ 2018-07-04T15:26:37+00:00 https://www.pharmaceutical-business-review.com/news/synlogic-gets-orphan-drug-status-for-synb1618-to-treat-phenylketonuri-251017-5956139/ 2018-07-04T15:26:37+00:00 https://www.pharmaceutical-business-review.com/news/7f4a2clarient_launches_second_gene_mutation_test_for_colorectal_can/ 2018-07-04T15:26:38+00:00 https://www.pharmaceutical-business-review.com/news/gileads-gs-0976-shows-positive-effect-in-mid-stage-nash-study-5956134/ 2018-07-04T15:26:39+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-alector-to-develop-novel-treatments-for-alzheimers-disease-251017-5955901/ 2018-07-04T15:26:39+00:00 https://www.pharmaceutical-business-review.com/news/0c48ccubist_pharmaceuticals_names_new_chief_medical_of/ 2018-07-04T15:26:39+00:00 https://www.pharmaceutical-business-review.com/news/c2483response_biomedical_initiates_respiratory_syncytial_virus_infection_/ 2018-07-04T15:26:39+00:00 https://www.pharmaceutical-business-review.com/news/8d4bcprotalix_completes_enrollment_in_phase_iii_gaucher_disease_tr/ 2018-07-04T15:26:39+00:00 https://www.pharmaceutical-business-review.com/news/bd4a6torreypiness_phase_ii_xerostomia_trial_meets_primary_end/ 2018-07-04T15:26:39+00:00 https://www.pharmaceutical-business-review.com/news/clinigen-acquires-japanese-unlicensed-medicines-supplier-241017-5955003/ 2018-07-04T15:26:40+00:00 https://www.pharmaceutical-business-review.com/news/global-blood-therapeutics-to-terminate-studies-of-idiopathic-pulmonary-fibrosis-program-241017-5954997/ 2018-07-04T15:26:42+00:00 https://www.pharmaceutical-business-review.com/news/6648dmako_surgical_wins_fda_clearance_for_two_new_pro/ 2018-07-04T15:26:42+00:00 https://www.pharmaceutical-business-review.com/news/9d48fcerimon_pharmaceuticals_names_new_board_m/ 2018-07-04T15:26:42+00:00 https://www.pharmaceutical-business-review.com/news/8148amylan_signs_settlement_agreement_with_novartis_for_generic_cancer/ 2018-07-04T15:26:42+00:00 https://www.pharmaceutical-business-review.com/news/914a9tyrx_names_ne/ 2018-07-04T15:26:43+00:00 https://www.pharmaceutical-business-review.com/news/224bbnicox_signs_manufacturing_and_supply_agreement_wit/ 2018-07-04T15:26:43+00:00 https://www.pharmaceutical-business-review.com/news/novartis-melanoma-therapy-tafinlar-mekinist-gets-fda-breakthrough-therapy-designation-241017-5954953/ 2018-07-04T15:26:43+00:00 https://www.pharmaceutical-business-review.com/news/adc-therapeutics-raises-200m-to-advance-lead-cancer-programs-241017-5954765/ 2018-07-04T15:26:43+00:00 https://www.pharmaceutical-business-review.com/news/celgene-to-stop-clinical-trials-of-crohns-disease-drug-ged-0301-231017-5954029/ 2018-07-04T15:26:45+00:00 https://www.pharmaceutical-business-review.com/news/0749faddex_initiates_phase_iib_gastroesophageal_reflux_disease_/ 2018-07-04T15:26:46+00:00 https://www.pharmaceutical-business-review.com/news/644b8sciclone_pharmaceuticals_names_ne/ 2018-07-04T15:26:46+00:00 https://www.pharmaceutical-business-review.com/news/aurinia-to-expand-voclosoprin-renal-franchise-231017-5953881/ 2018-07-04T15:26:46+00:00 https://www.pharmaceutical-business-review.com/news/janssen-gets-two-us-fda-approvals-for-simponi-aria-to-treat-active-psoriatic-arthritis-and-active-ankylosing-spondylitis-231017-5953872/ 2018-07-04T15:26:46+00:00 https://www.pharmaceutical-business-review.com/news/4248fsucampo_completes_enrollment_in_two_phase_iii_obd_t/ 2018-07-04T15:26:47+00:00 https://www.pharmaceutical-business-review.com/news/5d4a1pressure_products_wins_fda_clearance_for_safesept_transseptal_guidewir/ 2018-07-04T15:26:47+00:00 https://www.pharmaceutical-business-review.com/news/924b1dsm_to_sell_solutech_business_to_l/ 2018-07-04T15:26:47+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-gsks-shingrix-for-prevention-of-shingles-231017-5953664/ 2018-07-04T15:26:49+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-partners-with-target-to-progress-nash-research-5952981/ 2018-07-04T15:26:49+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-vir-to-jointly-advance-rnai-therapeutics-for-infectious-diseases-201017-5952893/ 2018-07-04T15:26:49+00:00 https://www.pharmaceutical-business-review.com/news/834bdgsk_and_theravance_report_positive_results_from_phase_iib_asthma_/ 2018-07-04T15:26:50+00:00 https://www.pharmaceutical-business-review.com/news/prostrakan_licenses_testosterone_gel_to_bayer_schering_pharma_021208/ 2018-07-04T15:26:50+00:00 https://www.pharmaceutical-business-review.com/news/pharming_completes_phase_i_study_of_anti_age_drug_021208/ 2018-07-04T15:26:50+00:00 https://www.pharmaceutical-business-review.com/news/lux_biosciencess_pip_for_uveitis_drug_wins_european_positive_opinion_021208/ 2018-07-04T15:26:51+00:00 https://www.pharmaceutical-business-review.com/news/helsinn_healthcare_signs_partnership_agreement_with_zealand_pharma_021208/ 2018-07-04T15:26:51+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-kites-car-t-therapy-yescarta-for-b-cell-lymphoma-201017-5952684/ 2018-07-04T15:26:52+00:00 https://www.pharmaceutical-business-review.com/news/teva-seeks-fda-approval-for-migraine-drug-fremanezumab-191017-5952194/ 2018-07-04T15:26:52+00:00 https://www.pharmaceutical-business-review.com/news/takeda-hemoshear-collaborate-to-develop-drugs-for-liver-diseases-181017-5951948/ 2018-07-04T15:26:52+00:00 https://www.pharmaceutical-business-review.com/news/compugen_signs_collaboration_agreement_with_merck_021208/ 2018-07-04T15:26:54+00:00 https://www.pharmaceutical-business-review.com/news/ceregene_reports_clinical_data_from_phase_ii_parkinsons_trial_021208/ 2018-07-04T15:26:54+00:00 https://www.pharmaceutical-business-review.com/news/cephalon_and_eurand_file_lawsuit_against_mylan_and_barr_pharmaceuticals_021208/ 2018-07-04T15:26:54+00:00 https://www.pharmaceutical-business-review.com/news/arana_therapeutics_to_initiate_pilot_study_of_rheumatoid_arthritis_021208/ 2018-07-04T15:26:55+00:00 https://www.pharmaceutical-business-review.com/news/ignytas-entrectinib-gets-ema-prime-designation-for-ntrk-fusion-positive-solid-tumors-181017-5951699/ 2018-07-04T15:26:56+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-accepts-sbla-for-imfinzi-in-locally-advanced-and-unresectable-nsclc-181017-5951694/ 2018-07-04T15:26:56+00:00 https://www.pharmaceutical-business-review.com/news/amneal-to-acquire-impax-to-expand-generics-business-in-us-181017-5951554/ 2018-07-04T15:26:56+00:00 https://www.pharmaceutical-business-review.com/news/d349aactavis_wins_fda_approval_to_market_generic_depression_d/ 2018-07-04T15:26:58+00:00 https://www.pharmaceutical-business-review.com/news/22484interbody_innovations_changes_name_to_ver/ 2018-07-04T15:26:58+00:00 https://www.pharmaceutical-business-review.com/news/244abhtg_signs_collaboration_agreement_with_harvard_catalyst_labor/ 2018-07-04T15:26:58+00:00 https://www.pharmaceutical-business-review.com/news/3b49fquintiles_acquires_targeted_molecular_diagno/ 2018-07-04T15:26:59+00:00 https://www.pharmaceutical-business-review.com/news/2148bsynovis_life_technologies_names_new_vice_president_o/ 2018-07-04T15:26:59+00:00 https://www.pharmaceutical-business-review.com/news/exelixis-liver-cancer-drug-cabozantinib-meets-primary-end-point-in-phase-3-trial-171017-5950776/ 2018-07-04T15:26:59+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-lung-cancer-drug-lorlatinib-succeeds-in-phase-2-trial-171017-5950703/ 2018-07-04T15:26:59+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-accepts-bms-application-for-opdivo-nivolumab-in-patients-with-resected-high-risk-advanced-melanoma-171017-5950705/ 2018-07-04T15:27:00+00:00 https://www.pharmaceutical-business-review.com/news/8148edexcom_wins_ce_mark_for_seven_glucose_monitoring_s/ 2018-07-04T15:27:01+00:00 https://www.pharmaceutical-business-review.com/news/12481acorda_therapeutics_names_new_board_m/ 2018-07-04T15:27:02+00:00 https://www.pharmaceutical-business-review.com/news/0a491qatar_and_egypt_join_hands_to_set_up_new_pharmaceutical_/ 2018-07-04T15:27:02+00:00 https://www.pharmaceutical-business-review.com/news/ed49dvical_obtains_1_million_milestone_payment_from_/ 2018-07-04T15:27:02+00:00 https://www.pharmaceutical-business-review.com/news/3b4a2nice_likely_to_lift_ban_on_kidney_cancer_dr/ 2018-07-04T15:27:02+00:00 https://www.pharmaceutical-business-review.com/news/e8484taligen_therapeutics_announces_senior_management_ch/ 2018-07-04T15:27:04+00:00 https://www.pharmaceutical-business-review.com/news/miragen-therapeutics-reports-positive-clinical-data-of-mrg-106-in-patients-with-mycosis-fungoides-form-of-cutaneous-t-cell-lymphoma-161017-5949542/ 2018-07-04T15:27:04+00:00 https://www.pharmaceutical-business-review.com/news/uks-nice-makes-nivolumab-available-for-head-and-neck-cancer-patients-161017-5949471/ 2018-07-04T15:27:04+00:00 https://www.pharmaceutical-business-review.com/news/47496anulex_technologies_names_new_president_an/ 2018-07-04T15:27:05+00:00 https://www.pharmaceutical-business-review.com/news/1e49epressure_biosciences_closes_rd_fac/ 2018-07-04T15:27:05+00:00 https://www.pharmaceutical-business-review.com/news/1c486zimmer_holdings_names_new_president_of_reconstructive_opera/ 2018-07-04T15:27:05+00:00 https://www.pharmaceutical-business-review.com/news/364aejohnson__johnson_to_acquire_mentor_for_107_bi/ 2018-07-04T15:27:05+00:00 https://www.pharmaceutical-business-review.com/news/fda-panel-backs-approval-of-aeries-rhopressa-for-glaucoma-treatment-161017-5949165/ 2018-07-04T15:27:06+00:00 https://www.pharmaceutical-business-review.com/news/moleculin-enters-into-strategic-collaboration-for-immune-stimulation-drug-131017-5948239/ 2018-07-04T15:27:06+00:00 https://www.pharmaceutical-business-review.com/news/human-clinical-trial-commences-for-first-leprosy-vaccine-candidate-131017-5948237/ 2018-07-04T15:27:06+00:00 https://www.pharmaceutical-business-review.com/news/fda-panel-supports-spark-gene-therapy-approval-for-rare-form-of-blindness-131017-5948021/ 2018-07-04T15:27:09+00:00 https://www.pharmaceutical-business-review.com/news/ardelyxs-phase-3-study-of-tenapanor-for-ibs-c-meets-primary-endpoint-121017-5946987/ 2018-07-04T15:27:09+00:00 https://www.pharmaceutical-business-review.com/news/9e4b9spectrascience_obtains_new_european_patent_for_optical_biopsy_s/ 2018-07-04T15:27:09+00:00 https://www.pharmaceutical-business-review.com/news/ce4b4fibrogen_names_new_chief_medical_of/ 2018-07-04T15:27:09+00:00 https://www.pharmaceutical-business-review.com/news/0248fs_bio_initiates_phase_iii_chronic_idiopathic_myelofibrosis_/ 2018-07-04T15:27:09+00:00 https://www.pharmaceutical-business-review.com/news/janssen-submits-nda-to-fda-for-apalutamide-to-treat-non-metastatic-castration-resistant-prostate-cancer-121017-5946992/ 2018-07-04T15:27:10+00:00 https://www.pharmaceutical-business-review.com/news/314aaallos_therapeutics_wins_fda_orphan_drug_designation_for_lymphoma/ 2018-07-04T15:27:10+00:00 https://www.pharmaceutical-business-review.com/news/7048canadys_wins_fda_fast_track_designation_for_hepatitis/ 2018-07-04T15:27:10+00:00 https://www.pharmaceutical-business-review.com/news/504b8ethicon_divests_professional_wound_care_portfolio_to_one_equity_par/ 2018-07-04T15:27:12+00:00 https://www.pharmaceutical-business-review.com/news/09497adhezion_biomedical_secures_525_million_in_series_a_fina/ 2018-07-04T15:27:12+00:00 https://www.pharmaceutical-business-review.com/news/dd4a6lexicon_files_investigational_new_drug_application_for_diabetes/ 2018-07-04T15:27:12+00:00 https://www.pharmaceutical-business-review.com/news/a1489endos_board_member_to_r/ 2018-07-04T15:27:12+00:00 https://www.pharmaceutical-business-review.com/news/lupin-buys-symbiomix-to-expand-womens-health-specialty-business-121017-5946788/ 2018-07-04T15:27:13+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-to-invest-170m-for-expansion-of-french-vaccine-manufacturing-facility-121017-5946904/ 2018-07-04T15:27:13+00:00 https://www.pharmaceutical-business-review.com/news/gilotrif-gets-fda-priority-review-for-uncommon-egfr-mutations-in-advanced-nsclc-5945734/ 2018-07-04T15:27:13+00:00 https://www.pharmaceutical-business-review.com/news/14495redpoint_bio_wins_two_new_us_patents_for_lowsodium_salt_subst/ 2018-07-04T15:27:13+00:00 https://www.pharmaceutical-business-review.com/news/7e4a4biovail_files_anda_for_generic_seroqu/ 2018-07-04T15:27:15+00:00 https://www.pharmaceutical-business-review.com/news/a74a0bradmer_wins_new_european_patent_for_use_of_neuradiab_in_lymphoma_trea/ 2018-07-04T15:27:16+00:00 https://www.pharmaceutical-business-review.com/news/9c4bdneurologica_introduces_new_ct_dose_reduction_sol/ 2018-07-04T15:27:16+00:00 https://www.pharmaceutical-business-review.com/news/9c4aegammadynacare_medical_to_acquire_central_medical_laborat/ 2018-07-04T15:27:16+00:00 https://www.pharmaceutical-business-review.com/news/e44b8sentinelle_medical_signs_oem_distribution_agreement_with_tosh/ 2018-07-04T15:27:16+00:00 https://www.pharmaceutical-business-review.com/news/moffitt-researchers-discover-new-targets-for-approved-cancer-drug-111017-5945825/ 2018-07-04T15:27:17+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-considers-sale-of-consumer-healthcare-business-111017-5945707/ 2018-07-04T15:27:17+00:00 https://www.pharmaceutical-business-review.com/news/shield-therapeutics-enrolls-patients-for-phase-3-study-of-ida-drug-feraccru-101017-5944797/ 2018-07-04T15:27:18+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-gets-fda-breakthrough-therapy-designation-for-tagrisso-101017-5944716/ 2018-07-04T15:27:20+00:00 https://www.pharmaceutical-business-review.com/news/a449eicad_to_launch_new_image_analysis_and_workflow_soluti/ 2018-07-04T15:27:20+00:00 https://www.pharmaceutical-business-review.com/news/a748alilly_withdraws_chronic_pain_application_for_cym/ 2018-07-04T15:27:20+00:00 https://www.pharmaceutical-business-review.com/news/f64b4impax_wins_final_fda_approval_for_generic_depression/ 2018-07-04T15:27:20+00:00 https://www.pharmaceutical-business-review.com/news/evotec-achieves-first-milestone-in-neurodegeneration-alliance-with-celgene-101017-5944720/ 2018-07-04T15:27:21+00:00 https://www.pharmaceutical-business-review.com/news/nanology-begins-nanopacs-phase-2-study-to-treat-ovarian-cancer-101017-5944706/ 2018-07-04T15:27:21+00:00 https://www.pharmaceutical-business-review.com/news/174a4astrazenecas_medimmune_wins_fda_complete_response_letter_for_motavi/ 2018-07-04T15:27:21+00:00 https://www.pharmaceutical-business-review.com/news/33484exonhit_launches_mouse_genome_splice/ 2018-07-04T15:27:21+00:00 https://www.pharmaceutical-business-review.com/news/panoptica-secures-11m-to-advance-clinical-development-novel-topical-anti-vegf-eye-drop-091017-5943802/ 2018-07-04T15:27:24+00:00 https://www.pharmaceutical-business-review.com/news/1a481mentice_introduces_two_new_products_for_endovascular_simulation_tra/ 2018-07-04T15:27:24+00:00 https://www.pharmaceutical-business-review.com/news/synthon-gets-regulatory-approval-for-glatiramer-acetate-40-mgml-in-europe-091017-5943791/ 2018-07-04T15:27:25+00:00 https://www.pharmaceutical-business-review.com/news/bayer-janssen-halt-phase-iii-navigate-esus-study-of-anticoagulant-medicine-xarelto-091017-5943648/ 2018-07-04T15:27:25+00:00 https://www.pharmaceutical-business-review.com/news/894b3kiadis_and_andrea_velardi_continue_collaboration_on_atir_develo/ 2018-07-04T15:27:25+00:00 https://www.pharmaceutical-business-review.com/news/f34a7tibotecs_hiv_drug_wins_european_positive_op/ 2018-07-04T15:27:25+00:00 https://www.pharmaceutical-business-review.com/news/b34bcsanofiaventis_signs_threeyear_contract_with_advanced_chemistry_develo/ 2018-07-04T15:27:25+00:00 https://www.pharmaceutical-business-review.com/news/29490pacsgear_introduces_pacsscan_film_for_mammog/ 2018-07-04T15:27:26+00:00 https://www.pharmaceutical-business-review.com/news/a24a2johnson__johnson_receives_fda_complete_response_letter_for_ceftobi/ 2018-07-04T15:27:28+00:00 https://www.pharmaceutical-business-review.com/news/3349eepivax_wins_390000_grant_from_nih_to_optimize_hiv_vaccine_deliv/ 2018-07-04T15:27:28+00:00 https://www.pharmaceutical-business-review.com/news/fd48dwyeth_and_progenics_report_positive_results_from_phase_iii_study_of_rel/ 2018-07-04T15:27:29+00:00 https://www.pharmaceutical-business-review.com/news/514b6sosei_group_licenses_malaria_drug_to_tr/ 2018-07-04T15:27:29+00:00 https://www.pharmaceutical-business-review.com/news/kadmons-cgvhd-drug-gets-fda-orphan-drug-designation-091017-5943877/ 2018-07-04T15:27:29+00:00 https://www.pharmaceutical-business-review.com/news/visterra-closes-467m-series-c-financing-to-advance-pipeline-of-precision-antibody-based-biological-medicines-061017-5942567/ 2018-07-04T15:27:29+00:00 https://www.pharmaceutical-business-review.com/news/ab4afencorium_q3_net_loss_w/ 2018-07-04T15:27:30+00:00 https://www.pharmaceutical-business-review.com/news/anthem-healthcore-boehringer-initiate-pragmatic-clinical-trial-to-study-people-living-with-copd-in-real-world-setting-061017-5942545/ 2018-07-04T15:27:30+00:00 https://www.pharmaceutical-business-review.com/news/c54aaplc_systems_wins_fda_approval_for_renalguard_study_/ 2018-07-04T15:27:33+00:00 https://www.pharmaceutical-business-review.com/news/5d4a9sorin_group_launches_new_crt_defibril/ 2018-07-04T15:27:33+00:00 https://www.pharmaceutical-business-review.com/news/824bbusystems_to_initiate_breast_cancer_screening_/ 2018-07-04T15:27:33+00:00 https://www.pharmaceutical-business-review.com/news/f6484spectrum_and_cell_therapeutics_form_jv_to_market_lymphoma/ 2018-07-04T15:27:33+00:00 https://www.pharmaceutical-business-review.com/news/dna-based-vaccine-produces-anti-zika-response-in-phase-1-human-trial-5942413/ 2018-07-04T15:27:33+00:00 https://www.pharmaceutical-business-review.com/news/ligand-to-acquire-crystal-bioscience-051017-5941360/ 2018-07-04T15:27:33+00:00 https://www.pharmaceutical-business-review.com/news/motif-bios-iclaprim-meets-primary-endpoint-in-second-phase-3-abssi-trial-051017-5941245/ 2018-07-04T15:27:33+00:00 https://www.pharmaceutical-business-review.com/news/8a4b0regen_signs_testmarketing_agreement_with_t/ 2018-07-04T15:27:34+00:00 https://www.pharmaceutical-business-review.com/news/recursion-pharmaceuticals-raises-60m-to-industrialize-drug-discovery-using-artificial-intelligence-051017-5941343/ 2018-07-04T15:27:36+00:00 https://www.pharmaceutical-business-review.com/news/324a0amorfix_achieves_final_milestone_under_option_agreement_with_biogen/ 2018-07-04T15:27:37+00:00 https://www.pharmaceutical-business-review.com/news/794bconcology_services_europe_launches_indian_opera/ 2018-07-04T15:27:37+00:00 https://www.pharmaceutical-business-review.com/news/ab4a0ortoviva_wins_ce_approval_for_distractor_s/ 2018-07-04T15:27:37+00:00 https://www.pharmaceutical-business-review.com/news/amgen-cytomx-partner-to-develop-immuno-oncology-drugs-051017-5941241/ 2018-07-04T15:27:37+00:00 https://www.pharmaceutical-business-review.com/news/immatics-secures-funding-to-develop-t-cell-receptor-based-immunotherapies-041017-5940552/ 2018-07-04T15:27:37+00:00 https://www.pharmaceutical-business-review.com/news/de4acanaspec_and_biogenuix_medsystems_sign_distribution_agre/ 2018-07-04T15:27:38+00:00 https://www.pharmaceutical-business-review.com/news/a9493barr_confirms_patent_challenge_of_amrix_extendedrelease_cap/ 2018-07-04T15:27:38+00:00 https://www.pharmaceutical-business-review.com/news/oxford-university-begins-human-trial-for-universal-flu-vaccine-041017-5940113/ 2018-07-04T15:27:40+00:00 https://www.pharmaceutical-business-review.com/news/x-chem-further-expands-collaboration-with-bayer-to-discover-novel-medicines-041017-5940142/ 2018-07-04T15:27:40+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-completes-acquisition-of-kite-pharma-041017-5940132/ 2018-07-04T15:27:40+00:00 https://www.pharmaceutical-business-review.com/news/484bedatascope_to_sell_evh_business_to_sorin_/ 2018-07-04T15:27:41+00:00 https://www.pharmaceutical-business-review.com/news/734b6hemispherx_biopharma_names_new_board_m/ 2018-07-04T15:27:41+00:00 https://www.pharmaceutical-business-review.com/news/ca485watson_wins_fda_approval_for_generic_depression/ 2018-07-04T15:27:41+00:00 https://www.pharmaceutical-business-review.com/news/f54a1lombard_medical_technologies_wins_russian_approval_for_aorfix_stent_/ 2018-07-04T15:27:42+00:00 https://www.pharmaceutical-business-review.com/news/01484introgens_president_and_ceo_resigns_company_cuts_down_30/ 2018-07-04T15:27:42+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-gets-fda-breakthrough-therapy-status-for-hodgkin-lymphoma-treatment-adcetris-031017-5939205/ 2018-07-04T15:27:43+00:00 https://www.pharmaceutical-business-review.com/news/ablynxs-blood-disease-drug-caplacizumab-passes-phase-3-attp-trial-031017-5939077/ 2018-07-04T15:27:44+00:00 https://www.pharmaceutical-business-review.com/news/endocyte-announces-exclusive-worldwide-license-of-psma-targeted-radioligand-therapy-for-development-in-prostate-cancer-031017-5939058/ 2018-07-04T15:27:44+00:00 https://www.pharmaceutical-business-review.com/news/404adwyeth_names_new_president_and_managing_director_of_canadian_opera/ 2018-07-04T15:27:45+00:00 https://www.pharmaceutical-business-review.com/news/ca4a1pfizer_wins_fda_approval_for_hiv/ 2018-07-04T15:27:45+00:00 https://www.pharmaceutical-business-review.com/news/6a4a2perkinelmer_names_new_vice_president_of_cellular_imaging_and_ana/ 2018-07-04T15:27:45+00:00 https://www.pharmaceutical-business-review.com/news/24482aspect_medical_systemss_cfo_to_r/ 2018-07-04T15:27:46+00:00 https://www.pharmaceutical-business-review.com/news/944b4torreypines_buys_royalty_rate_reduction_from_eli_/ 2018-07-04T15:27:46+00:00 https://www.pharmaceutical-business-review.com/news/us-hhs-accelerates-development-of-first-ebola-vaccines-and-drugs-031017-5939050/ 2018-07-04T15:27:47+00:00 https://www.pharmaceutical-business-review.com/news/roches-perjeta-regimen-secures-fda-priority-review-in-breast-cancer-290917-5938563/ 2018-07-04T15:27:47+00:00 https://www.pharmaceutical-business-review.com/news/merck-halts-development-of-mk-3682b-and-mk-3682c-programs-290917-5938629/ 2018-07-04T15:27:47+00:00 https://www.pharmaceutical-business-review.com/news/9d4adpyng_medical_names_new_vice_president_of_us_/ 2018-07-04T15:27:48+00:00 https://www.pharmaceutical-business-review.com/news/2f495daiichi_sankyo_establishes_new_subsidiary_in_ir/ 2018-07-04T15:27:49+00:00 https://www.pharmaceutical-business-review.com/news/ad492peregrine_wins_new_us_antiviral_p/ 2018-07-04T15:27:49+00:00 https://www.pharmaceutical-business-review.com/news/8a499kcis_subsidiary_wins_ce_mark_for_strattice_reconstructive_tissue_m/ 2018-07-04T15:27:49+00:00 https://www.pharmaceutical-business-review.com/news/ea4adcvbt_initiates_dosing_in_phase_ii_coronary_heart_disease_/ 2018-07-04T15:27:49+00:00 https://www.pharmaceutical-business-review.com/news/zynerba-cannabis-derived-gel-for-fragile-x-syndrome-succeeds-in-phase-2-trial-290917-5938240/ 2018-07-04T15:27:50+00:00 https://www.pharmaceutical-business-review.com/news/novartis-uc-berkeley-collaborate-to-tackle-undruggable-disease-targets-290917-5938124/ 2018-07-04T15:27:51+00:00 https://www.pharmaceutical-business-review.com/news/tricida-begins-phase-3-study-of-trc101-to-treat-metabolic-acidosis-associated-with-chronic-kidney-disease-290917-5938117/ 2018-07-04T15:27:51+00:00 https://www.pharmaceutical-business-review.com/news/da4act2cure_acquires_patent_family_from_innov/ 2018-07-04T15:27:53+00:00 https://www.pharmaceutical-business-review.com/news/dc48elight_sciences_oncology_completes_enrollment_in_phase_iii_liver_cancer_/ 2018-07-04T15:27:53+00:00 https://www.pharmaceutical-business-review.com/news/bd481watson_to_acquire_generic_product_portfolio_from/ 2018-07-04T15:27:53+00:00 https://www.pharmaceutical-business-review.com/news/evotec-buys-stake-in-exscientia-to-advance-ai-based-drug-discovery-290917-5937874/ 2018-07-04T15:27:54+00:00 https://www.pharmaceutical-business-review.com/news/6a49fabraxis_signs_agreement_with_astrazeneca_to_reacquire_us_rights_to_abr/ 2018-07-04T15:27:54+00:00 https://www.pharmaceutical-business-review.com/news/b04bdcellectricon_and_harvard_medical_school_form_collabor/ 2018-07-04T15:27:54+00:00 https://www.pharmaceutical-business-review.com/news/md-anderson-cancer-center-pfizer-oncology-partner-to-assess-immuno-oncology-combinations-in-blood-cancers-and-solid-tumors-280917-5937107/ 2018-07-04T15:27:55+00:00 https://www.pharmaceutical-business-review.com/news/immunes-bertilimumab-yields-positive-results-in-phase-2-bullous-pemphigoid-trial-280917-5937100/ 2018-07-04T15:27:55+00:00 https://www.pharmaceutical-business-review.com/news/174a1penwest_signs_second_rd_agreement_with_otsuka_pharmaceu/ 2018-07-04T15:27:56+00:00 https://www.pharmaceutical-business-review.com/news/jacobs-secures-contract-from-ferring-pharmaceuticals-for-research-and-development-headquarters-in-copenhagen-280917-5937092/ 2018-07-04T15:27:57+00:00 https://www.pharmaceutical-business-review.com/news/214a5dor_biopharmas_gvhd_drug_wins_orphan_drug_designation_in_aust/ 2018-07-04T15:27:57+00:00 https://www.pharmaceutical-business-review.com/news/e6492ra_group_holdings_to_acquire_national_renal_all/ 2018-07-04T15:27:57+00:00 https://www.pharmaceutical-business-review.com/news/e34a3dako_signs_new_collaboration_agreement_with_gene/ 2018-07-04T15:27:57+00:00 https://www.pharmaceutical-business-review.com/news/4e4aeprovectus_reaches_halfway_point_in_enrollment_for_phase_ii_melanoma_/ 2018-07-04T15:27:57+00:00 https://www.pharmaceutical-business-review.com/news/bevespi-aerosphere-demonstrates-statistically-significant-improvement-in-lung-function-in-patients-with-copd-270917-5935913/ 2018-07-04T15:27:58+00:00 https://www.pharmaceutical-business-review.com/news/autolus-secures-80m-series-c-funding-270917-5935884/ 2018-07-04T15:27:58+00:00 https://www.pharmaceutical-business-review.com/news/axovants-alzheimers-drug-intepirdine-fails-in-phase-3-trial-270917-5935763/ 2018-07-04T15:28:01+00:00 https://www.pharmaceutical-business-review.com/news/newlink-genetics-announces-clinical-collaboration-to-assess-io-based-combination-therapies-in-pancreatic-cancer-260917-5934702/ 2018-07-04T15:28:01+00:00 https://www.pharmaceutical-business-review.com/news/janssen-receives-complete-response-letter-from-us-fda-for-sirukumab-biologics-license-application-260917-5934688/ 2018-07-04T15:28:01+00:00 https://www.pharmaceutical-business-review.com/news/ed499surmodics_names_new_board_m/ 2018-07-04T15:28:01+00:00 https://www.pharmaceutical-business-review.com/news/3b486sigmaaldrich_and_dfinitive_cell_technologies_form_research_collabor/ 2018-07-04T15:28:01+00:00 https://www.pharmaceutical-business-review.com/news/ab4b3teva_signs_settlement_agreement_with_astraz/ 2018-07-04T15:28:01+00:00 https://www.pharmaceutical-business-review.com/news/944bbsun_pharmas_us_subsidiary_acquires_chattem_chemic/ 2018-07-04T15:28:02+00:00 https://www.pharmaceutical-business-review.com/news/b64b4exact_sciences_names_new_board_m/ 2018-07-04T15:28:02+00:00 https://www.pharmaceutical-business-review.com/news/0c4b7emisphere_announces_positive_results_from_oral_parathyroid_hormone_/ 2018-07-04T15:28:04+00:00 https://www.pharmaceutical-business-review.com/news/3648erxelite_terminates_distribution_agreement_with_minrad_internat/ 2018-07-04T15:28:04+00:00 https://www.pharmaceutical-business-review.com/news/7349eeastmed_wins_clearance_to_market_urinary_incontinence_product_/ 2018-07-04T15:28:04+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-spins-off-new-company-with-four-rare-disease-therapies-260917-5934483/ 2018-07-04T15:28:05+00:00 https://www.pharmaceutical-business-review.com/news/salvarx-immunova-establish-new-jv-firm-saugatuck-therapeutics-250917-5933810/ 2018-07-04T15:28:05+00:00 https://www.pharmaceutical-business-review.com/news/99485ocimum_biosolutions_to_distribute_clarmons_compliance_management_sol/ 2018-07-04T15:28:05+00:00 https://www.pharmaceutical-business-review.com/news/4f4bfnuvos_subsidiary_forms_rd_collaboration_with_fortune_global_500_co/ 2018-07-04T15:28:05+00:00 https://www.pharmaceutical-business-review.com/news/landos-biopharma-raises-10m-in-series-a-financing-250917-5933472/ 2018-07-04T15:28:06+00:00 https://www.pharmaceutical-business-review.com/news/eleven-biotherapeutics-completes-vicinium-manufacturing-for-ongoing-clinical-trials-in-non-muscle-invasive-bladder-cancer-250917-5933450/ 2018-07-04T15:28:09+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-bristol-myers-to-evaluate-abbv-399opdivo-regimen-in-advanced-solid-tumors-250917-5933265/ 2018-07-04T15:28:09+00:00 https://www.pharmaceutical-business-review.com/news/cf4aftomtec_and_medis_introduce_joint_cardiac_imaging_and_analysis_pr/ 2018-07-04T15:28:09+00:00 https://www.pharmaceutical-business-review.com/news/ac4b5poniard_pharmaceuticals_announces_senior_management_ch/ 2018-07-04T15:28:09+00:00 https://www.pharmaceutical-business-review.com/news/versartis-phase-3-velocity-trial-of-somavaratan-in-pediatric-growth-hormone-deficiency-did-not-meet-primary-endpoint-220917-5932140/ 2018-07-04T15:28:10+00:00 https://www.pharmaceutical-business-review.com/news/f6483bayer_agrees_to_pay_975_million_to_settle_kickback_prob/ 2018-07-04T15:28:10+00:00 https://www.pharmaceutical-business-review.com/news/484b1virtual_radiologic_forms_technology_partnership_with_pro/ 2018-07-04T15:28:10+00:00 https://www.pharmaceutical-business-review.com/news/0f4a1dfb_pharmaceuticals_appoints_president_and_ceo_of_healthpo/ 2018-07-04T15:28:10+00:00 https://www.pharmaceutical-business-review.com/news/merck-pfizer-get-ec-approval-for-bavencio-for-metastatic-merkel-cell-carcinoma-220917-5931996/ 2018-07-04T15:28:12+00:00 https://www.pharmaceutical-business-review.com/news/roche-gets-ec-nod-for-gazyvaro-to-treat-advanced-follicular-lymphoma-220917-5932107/ 2018-07-04T15:28:13+00:00 https://www.pharmaceutical-business-review.com/news/milliporesigma-opens-chinas-first-end-to-end-biodevelopment-center-in-shanghai-220917-5932123/ 2018-07-04T15:28:13+00:00 https://www.pharmaceutical-business-review.com/news/bf495roche_scraps_skyscraper_hq_to_develop_alternative_pr/ 2018-07-04T15:28:15+00:00 https://www.pharmaceutical-business-review.com/news/a94a5geneart_wins_contract_from_wellcome_trust_sanger_inst/ 2018-07-04T15:28:15+00:00 https://www.pharmaceutical-business-review.com/news/10495cepheid_obtains_health_canada_license_for_mrsasa/ 2018-07-04T15:28:16+00:00 https://www.pharmaceutical-business-review.com/news/a74beantigenics_presents_positive_data_from_phase_i_brain_tumor_/ 2018-07-04T15:28:16+00:00 https://www.pharmaceutical-business-review.com/news/844a9xdx_announces_corporate_restructuring_cuts_25/ 2018-07-04T15:28:16+00:00 https://www.pharmaceutical-business-review.com/news/cavion-recruits-first-patient-in-multi-center-phase-2-clinical-trial-in-essential-tremor-210917-5931105/ 2018-07-04T15:28:17+00:00 https://www.pharmaceutical-business-review.com/news/gsk-astrazeneca-labcyte-form-alliance-to-develop-acoustic-mass-spectrometry-210917-5931093/ 2018-07-04T15:28:17+00:00 https://www.pharmaceutical-business-review.com/news/novartis-rydapt-approved-in-europe-for-aml-and-rare-blood-disorders-210917-5930884/ 2018-07-04T15:28:17+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-announces-outcome-of-fda-advisory-committee-meeting-for-sutent-in-patients-at-high-risk-of-recurrent-renal-cell-carcinoma-after-surgery-5929814/ 2018-07-04T15:28:20+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-gets-ec-approval-for-xermelo-to-treat-carcinoid-syndrome-diarrhea-200917-5929806/ 2018-07-04T15:28:20+00:00 https://www.pharmaceutical-business-review.com/news/gsk-innoviva-get-fda-nod-for-copd-treatment-trelegy-ellipta-200917-5929780/ 2018-07-04T15:28:20+00:00 https://www.pharmaceutical-business-review.com/news/catalent-to-acquire-indiana-based-cdmo-cook-pharmica-for-950m-200917-5929695/ 2018-07-04T15:28:23+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-motif-bios-iclaprim-to-treat-staphylococcus-aureus-lung-infections-in-patients-with-cystic-fibrosis-190917-5928703/ 2018-07-04T15:28:24+00:00 https://www.pharmaceutical-business-review.com/news/ultragenyx-proposes-to-acquire-dimension-therapeutics-190917-5928690/ 2018-07-04T15:28:24+00:00 https://www.pharmaceutical-business-review.com/news/f8498elan_names_new_senior_vice_president_and_head_of_corporate_rela/ 2018-07-04T15:28:26+00:00 https://www.pharmaceutical-business-review.com/news/4a483roche_to_acquire_memory_pharmaceuticals_for_50_mi/ 2018-07-04T15:28:26+00:00 https://www.pharmaceutical-business-review.com/news/264abdentsply_to_acquire_majority_interest_in_zherm/ 2018-07-04T15:28:27+00:00 https://www.pharmaceutical-business-review.com/news/0f4bdavi_biopharma_signs_licensing_agreement_with_university_of_western_aust/ 2018-07-04T15:28:27+00:00 https://www.pharmaceutical-business-review.com/news/f2492visage_imaging_signs_marketing_agreement_with_viat/ 2018-07-04T15:28:27+00:00 https://www.pharmaceutical-business-review.com/news/roches-venclextavenclyxto-succeeds-in-phase-3-chronic-lymphocytic-leukaemia-study-190917-5928555/ 2018-07-04T15:28:28+00:00 https://www.pharmaceutical-business-review.com/news/teva-to-divest-specialty-global-womens-health-business-for-248bn-190917-5928639/ 2018-07-04T15:28:29+00:00 https://www.pharmaceutical-business-review.com/news/chmp-recommends-gsk-innovivas-single-inhaler-triple-therapy-for-copd-180917-5927633/ 2018-07-04T15:28:29+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-receives-positive-chmp-opinion-for-adalimumab-biosimilar-cyltezo-180917-5927639/ 2018-07-04T15:28:32+00:00 https://www.pharmaceutical-business-review.com/news/mustang-bio-announces-expansion-of-car-t-pipeline-into-cd20-directed-immunotherapies-180917-5927629/ 2018-07-04T15:28:32+00:00 https://www.pharmaceutical-business-review.com/news/83487proveris_scientific_establishes_new_european_headqua/ 2018-07-04T15:28:32+00:00 https://www.pharmaceutical-business-review.com/news/bydureon-exscel-trial-shows-favorable-cardiovascular-safety-profile-in-patients-with-type-2-diabetes-150917-5926678/ 2018-07-04T15:28:33+00:00 https://www.pharmaceutical-business-review.com/news/b7490tigermed_forms_partnerships_with_cros_in_russia_and_/ 2018-07-04T15:28:33+00:00 https://www.pharmaceutical-business-review.com/news/2b48cpremd_enters_clinical_study_with_cosmetics_conglom/ 2018-07-04T15:28:33+00:00 https://www.pharmaceutical-business-review.com/news/9d49adr_reddys_introduces_generic_imitrex_tablets_in/ 2018-07-04T15:28:33+00:00 https://www.pharmaceutical-business-review.com/news/964a9covidien_and_depomed_sign_licensing_agre/ 2018-07-04T15:28:33+00:00 https://www.pharmaceutical-business-review.com/news/f048ddsm_biologics_and_crucell_sign_licensing_agreement_with_gedeon_ri/ 2018-07-04T15:28:36+00:00 https://www.pharmaceutical-business-review.com/news/754bbclinical_data_provides_genotyping_solutions_for_ast/ 2018-07-04T15:28:37+00:00 https://www.pharmaceutical-business-review.com/news/2e491antares_and_population_council_initiate_phase_ii_study_of_contraceptive_at/ 2018-07-04T15:28:37+00:00 https://www.pharmaceutical-business-review.com/news/634b9scheringplough_reports_topline_results_from_phase_iii_schizophrenia_/ 2018-07-04T15:28:37+00:00 https://www.pharmaceutical-business-review.com/news/5a4bbscheringploughs_phase_ii_parkinsons_trial_meets_primary_end/ 2018-07-04T15:28:37+00:00 https://www.pharmaceutical-business-review.com/news/vandas-tradipitant-improves-itch-and-disease-severity-in-patients-with-atopic-dermatitis-150917-5926666/ 2018-07-04T15:28:37+00:00 https://www.pharmaceutical-business-review.com/news/bms-to-use-halozymes-enhanze-technology-to-develop-immuno-oncology-medicines-150917-5926519/ 2018-07-04T15:28:38+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-bevacizumab-biosimilar-mvasi-for-five-types-of-cancer-150917-5926339/ 2018-07-04T15:28:38+00:00 https://www.pharmaceutical-business-review.com/news/fe48dscheringplough_to_develop_new_oral_hepatitis/ 2018-07-04T15:28:41+00:00 https://www.pharmaceutical-business-review.com/news/d148bgenzyme_files_snda_for_leukemia/ 2018-07-04T15:28:41+00:00 https://www.pharmaceutical-business-review.com/news/074a1terumo_heart_names_new_president_an/ 2018-07-04T15:28:41+00:00 https://www.pharmaceutical-business-review.com/news/204b4labopharms_nda_for_depression_drug_accepted_for_review_b/ 2018-07-04T15:28:41+00:00 https://www.pharmaceutical-business-review.com/news/berkeley-lights-bayer-partner-for-cell-line-development-and-antibody-discovery-140917-5925500/ 2018-07-04T15:28:41+00:00 https://www.pharmaceutical-business-review.com/news/inotek-pharmaceuticals-announces-merger-deal-with-rocket-pharmaceuticals-140917-5925487/ 2018-07-04T15:28:41+00:00 https://www.pharmaceutical-business-review.com/news/fda-advisory-panel-recommends-approval-of-gsks-shingles-vaccine-shingrix-140917-5925415/ 2018-07-04T15:28:41+00:00 https://www.pharmaceutical-business-review.com/news/194a3tomotherapy_names_new_vice_president_of_global_/ 2018-07-04T15:28:42+00:00 https://www.pharmaceutical-business-review.com/news/214b5diasome_pharmaceuticals_names_new_cha/ 2018-07-04T15:28:44+00:00 https://www.pharmaceutical-business-review.com/news/7a4bdmedarex_initiates_phase_ib_cancer_/ 2018-07-04T15:28:44+00:00 https://www.pharmaceutical-business-review.com/news/amicus-therapeutics-skin-disorder-drug-sd-101-fails-in-phase-3-trial-140917-5925388/ 2018-07-04T15:28:44+00:00 https://www.pharmaceutical-business-review.com/news/onxeos-liver-cancer-drug-livatag-fails-in-phase-3-trial-130917-5924364/ 2018-07-04T15:28:44+00:00 https://www.pharmaceutical-business-review.com/news/014acvaleant_reports_encouraging_results_from_phase_iib_hepatitis_/ 2018-07-04T15:28:45+00:00 https://www.pharmaceutical-business-review.com/news/63495poniard_pharmaceuticals_signs_supply_agreement_with_baxter_oncol/ 2018-07-04T15:28:45+00:00 https://www.pharmaceutical-business-review.com/news/1e482biovitrum_and_syntonix_win_orphan_drug_designation_for_hemophilia/ 2018-07-04T15:28:45+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-lung-cancer-drug-shows-significant-effect-in-pacific-trial-130917-5924372/ 2018-07-04T15:28:45+00:00 https://www.pharmaceutical-business-review.com/news/fe4a2ovation_announces_nationwide_availability_of_huntingtons_drug_/ 2018-07-04T15:28:49+00:00 https://www.pharmaceutical-business-review.com/news/724a1allos_wins_orphan_drug_designation_for_lymphoma/ 2018-07-04T15:28:49+00:00 https://www.pharmaceutical-business-review.com/news/irx-therapeutics-reports-positive-irx-2-phase-2a-head-and-neck-squamous-cell-carcinoma-clinical-results-120917-5923301/ 2018-07-04T15:28:49+00:00 https://www.pharmaceutical-business-review.com/news/hitgen-takeda-enter-dna-encoded-library-based-drug-discovery-research-collaboration-120917-5923294/ 2018-07-04T15:28:49+00:00 https://www.pharmaceutical-business-review.com/news/9e4b3cerus_initiates_phase_i_study_for_intercept_red_blood_cell_s/ 2018-07-04T15:28:50+00:00 https://www.pharmaceutical-business-review.com/news/044a3serviers_depression_drug_wins_eu_positive_op/ 2018-07-04T15:28:50+00:00 https://www.pharmaceutical-business-review.com/news/9949daeolus_initiates_animal_study_of_antiradiation/ 2018-07-04T15:28:50+00:00 https://www.pharmaceutical-business-review.com/news/janssen-scraps-hepatitis-c-development-amid-growing-number-of-therapies-120917-5923261/ 2018-07-04T15:28:52+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-gubra-to-develop-next-generation-obesity-treatments-110917-5922186/ 2018-07-04T15:28:53+00:00 https://www.pharmaceutical-business-review.com/news/tevas-migraine-drug-fremanezumab-succeeds-in-phase-3-studies-110917-5922144/ 2018-07-04T15:28:53+00:00 https://www.pharmaceutical-business-review.com/news/e448echemdiv_and_avineuro_extend_collabor/ 2018-07-04T15:28:54+00:00 https://www.pharmaceutical-business-review.com/news/98485paradigm_medical_names_new_pres/ 2018-07-04T15:28:54+00:00 https://www.pharmaceutical-business-review.com/news/8e483recordati_files_maa_application_for_bph_drug_/ 2018-07-04T15:28:54+00:00 https://www.pharmaceutical-business-review.com/news/d04b0amgens_bloodclot_drug_wins_eu_positive_op/ 2018-07-04T15:28:54+00:00 https://www.pharmaceutical-business-review.com/news/b848ebiomarins_chief_medical_officer_to_r/ 2018-07-04T15:28:54+00:00 https://www.pharmaceutical-business-review.com/news/european-investment-bank-grants-75m-funding-for-evotec-110917-5922015/ 2018-07-04T15:28:57+00:00 https://www.pharmaceutical-business-review.com/news/regeneron-sanofi-get-fda-breakthrough-therapy-status-for-skin-cancer-drug-cemiplimab-110917-5921873/ 2018-07-04T15:28:57+00:00 https://www.pharmaceutical-business-review.com/news/lilly-to-make-3500-roles-redundant-to-streamline-operations-080917-5920877/ 2018-07-04T15:28:57+00:00 https://www.pharmaceutical-business-review.com/news/kura-oncology-reports-positive-phase-2-study-for-tipifarnib-in-hras-mutant-head-and-neck-cancer-080917-5920974/ 2018-07-04T15:29:01+00:00 https://www.pharmaceutical-business-review.com/news/gsk-exercises-option-on-phase-iii-ny-eso-t-cell-therapy-080917-5920960/ 2018-07-04T15:29:01+00:00 https://www.pharmaceutical-business-review.com/news/astrazenecas-copd-drug-duaklir-met-primary-endpoints-in-phase-iii-amplify-trial-080917-5920632/ 2018-07-04T15:29:01+00:00 https://www.pharmaceutical-business-review.com/news/224a2lilly_completes_cash_tender_offer_for_imclone_syst/ 2018-07-04T15:29:04+00:00 https://www.pharmaceutical-business-review.com/news/2d4a4basileas_antimrsa_broadspectrum_antibiotic_wins_eu_positive_op/ 2018-07-04T15:29:04+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-resolves-us-allegations-on-victoza-for-58m-070917-5919695/ 2018-07-04T15:29:04+00:00 https://www.pharmaceutical-business-review.com/news/46482wyeths_new_indication_for_psoriasis_drug_wins_eu_positive_recommend/ 2018-07-04T15:29:05+00:00 https://www.pharmaceutical-business-review.com/news/77480escalon_medical_raises_11_million_in_equity_fina/ 2018-07-04T15:29:05+00:00 https://www.pharmaceutical-business-review.com/news/ed4a0invitrogen_and_applied_biosystems_complete_merger_transa/ 2018-07-04T15:29:05+00:00 https://www.pharmaceutical-business-review.com/news/bioverativ-bicycle-therapeutics-to-develop-therapies-for-hemophilia-and-sickle-cell-disease-070917-5919709/ 2018-07-04T15:29:05+00:00 https://www.pharmaceutical-business-review.com/news/path-boosts-leadership-in-developing-and-introducing-urgently-needed-vaccines-070917-5919679/ 2018-07-04T15:29:05+00:00 https://www.pharmaceutical-business-review.com/news/roches-lung-cancer-drug-alecensa-shows-significant-effect-in-global-phase-iii-study-070917-5919497/ 2018-07-04T15:29:07+00:00 https://www.pharmaceutical-business-review.com/news/avadel-pharmaceuticals-enters-into-exclusive-license-agreement-for-noctiva-060917-5918224/ 2018-07-04T15:29:07+00:00 https://www.pharmaceutical-business-review.com/news/deciphera-gets-fda-orphan-drug-designation-for-dcc-2618-to-treat-glioblastoma-multiforme-and-anaplastic-astrocytoma-060917-5918184/ 2018-07-04T15:29:07+00:00 https://www.pharmaceutical-business-review.com/news/27485cardiosolutions_names_new_chief_surgical_of/ 2018-07-04T15:29:08+00:00 https://www.pharmaceutical-business-review.com/news/484b7vital_images_and_toshiba_renew_distribution_agreem/ 2018-07-04T15:29:09+00:00 https://www.pharmaceutical-business-review.com/news/e94a9toshiba_acquires_advanced_visualization_business_from_/ 2018-07-04T15:29:09+00:00 https://www.pharmaceutical-business-review.com/news/3a487argos_therapeutics_raises_352_million_in_series_c_financ/ 2018-07-04T15:29:09+00:00 https://www.pharmaceutical-business-review.com/news/e64b6bioscrip_names_ne/ 2018-07-04T15:29:09+00:00 https://www.pharmaceutical-business-review.com/news/d148ajohnson__johnson_wins_fda_approval_for_pain/ 2018-07-04T15:29:12+00:00 https://www.pharmaceutical-business-review.com/news/bb48echimed_expands_drug_discovery_partnership_with_/ 2018-07-04T15:29:12+00:00 https://www.pharmaceutical-business-review.com/news/a449ecmed_raises_gbp5_million_in_fina/ 2018-07-04T15:29:12+00:00 https://www.pharmaceutical-business-review.com/news/0e4b9essentialis_completes_enrollment_in_phase_ii_dyslipidemia_/ 2018-07-04T15:29:12+00:00 https://www.pharmaceutical-business-review.com/news/3649dgsk_and_neptunus_to_form_jv_for_codevelopment_of_flu_vac/ 2018-07-04T15:29:12+00:00 https://www.pharmaceutical-business-review.com/news/ec-approves-mercks-keytruda-to-treat-bladder-cancer-060917-5918084/ 2018-07-04T15:29:12+00:00 https://www.pharmaceutical-business-review.com/news/midatech-submits-mtd201-cta-filing-for-first-in-human-study-in-carcinoid-cancer-and-acromegaly-050917-5917524/ 2018-07-04T15:29:12+00:00 https://www.pharmaceutical-business-review.com/news/tigenix-obtains-commercial-production-license-for-expanded-manufacturing-facility-050917-5917410/ 2018-07-04T15:29:12+00:00 https://www.pharmaceutical-business-review.com/news/novartis-multiple-sclerosis-drug-gilenya-shows-siginificant-effect-in-phase-iii-trial-050917-5917273/ 2018-07-04T15:29:14+00:00 https://www.pharmaceutical-business-review.com/news/29495aida_acquires_research_institute_in_ch/ 2018-07-04T15:29:15+00:00 https://www.pharmaceutical-business-review.com/news/oragenics-doses-first-patient-in-phase-2-clinical-trial-of-ag013-for-oral-mucositis-040917-5916474/ 2018-07-04T15:29:15+00:00 https://www.pharmaceutical-business-review.com/news/sunovion-seeks-fda-approval-for-dasotraline-to-treat-patients-with-adhd-040917-5916460/ 2018-07-04T15:29:15+00:00 https://www.pharmaceutical-business-review.com/news/bc484roche_wins_eu_positive_opinion_for_rheumatoid_arthritis/ 2018-07-04T15:29:16+00:00 https://www.pharmaceutical-business-review.com/news/2848asandoz_wins_eu_positive_opinion_for_neutropenia/ 2018-07-04T15:29:16+00:00 https://www.pharmaceutical-business-review.com/news/4d4aftakeda_files_marketing_application_for_oncedaily_formulation_of_diabetes/ 2018-07-04T15:29:16+00:00 https://www.pharmaceutical-business-review.com/news/7448fnicox_announces_positive_results_from_phase_iii_osteoarthritis_/ 2018-07-04T15:29:16+00:00 https://www.pharmaceutical-business-review.com/news/a44b5mediware_acquires_hanns_on_sof/ 2018-07-04T15:29:17+00:00 https://www.pharmaceutical-business-review.com/news/therapure-to-sell-contract-development-and-manufacturing-business-to-3sbio-040917-5916427/ 2018-07-04T15:29:19+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-gets-fda-nod-for-mylotarg-to-treat-acute-myeloid-leukemia-040917-5916212/ 2018-07-04T15:29:19+00:00 https://www.pharmaceutical-business-review.com/news/aptevo-therapeutics-to-sell-hyperimmune-commercial-products-010917-5915174/ 2018-07-04T15:29:19+00:00 https://www.pharmaceutical-business-review.com/news/4749dipsogen_introduces_new_tumor_test_in_e/ 2018-07-04T15:29:20+00:00 https://www.pharmaceutical-business-review.com/news/7a4a1merrion_and_novo_nordisk_sign_development_and_licensing_agre/ 2018-07-04T15:29:20+00:00 https://www.pharmaceutical-business-review.com/news/bf4acdyaxs_bla_for_angioedema_drug_wins_fda_priority_r/ 2018-07-04T15:29:21+00:00 https://www.pharmaceutical-business-review.com/news/1e4b7genentechs_phase_iii_breast_cancer_study_meets_end/ 2018-07-04T15:29:21+00:00 https://www.pharmaceutical-business-review.com/news/2c4a2biomimetic_therapeutics_announces_us_patent_allowance_for_pdgf_composi/ 2018-07-04T15:29:21+00:00 https://www.pharmaceutical-business-review.com/news/67496zymogenetics_names_ne/ 2018-07-04T15:29:23+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-takeda-to-develop-medi1341-for-parkinsons-disease-310817-5913754/ 2018-07-04T15:29:24+00:00 https://www.pharmaceutical-business-review.com/news/1f4a1sonosite_wins_portable_ultrasound_contract_from_healthtrust_purchasing_/ 2018-07-04T15:29:24+00:00 https://www.pharmaceutical-business-review.com/news/synvista_therapeutics_names_new_board_member/ 2018-07-04T15:29:24+00:00 https://www.pharmaceutical-business-review.com/news/biodel_obtains_notice_of_allowance_for_insulin_patent_claims_in_europe/ 2018-07-04T15:29:24+00:00 https://www.pharmaceutical-business-review.com/news/antares_pharma_names_new_president_and_ceo/ 2018-07-04T15:29:24+00:00 https://www.pharmaceutical-business-review.com/news/tick-saliva-may-reduce-hiv-linked-heart-disease-risk-says-scientists-010917-5915158/ 2018-07-04T15:29:24+00:00 https://www.pharmaceutical-business-review.com/news/bayer-submits-bla-to-fda-for-bay94-9027-to-treat-hemophilia-a-010917-5914994/ 2018-07-04T15:29:24+00:00 https://www.pharmaceutical-business-review.com/news/otonomys-otividex-fails-to-meet-primary-endpoint-in-phase-3-trial-for-mnires-disease-310817-5913748/ 2018-07-04T15:29:27+00:00 https://www.pharmaceutical-business-review.com/news/calypte_obtains_purchase_order_for_hiv_tests_from_middle_eastern_distributor/ 2018-07-04T15:29:27+00:00 https://www.pharmaceutical-business-review.com/news/nti_plans_to_consolidate_phase_iii_ischemic_stroke_trial_data/ 2018-07-04T15:29:27+00:00 https://www.pharmaceutical-business-review.com/news/novartis-gets-fda-nod-for-cancer-treatment-kymriah-310817-5913594/ 2018-07-04T15:29:28+00:00 https://www.pharmaceutical-business-review.com/news/jazz-immunogen-to-collaborate-on-hematology-related-adc-products-300817-5912621/ 2018-07-04T15:29:28+00:00 https://www.pharmaceutical-business-review.com/news/gtxs_phase_ii_cancer_cachexia_trial_meets_endpoint/ 2018-07-04T15:29:28+00:00 https://www.pharmaceutical-business-review.com/news/integra_lifesciences_launches_luxtec_mlx_300w_xenon_light_source/ 2018-07-04T15:29:28+00:00 https://www.pharmaceutical-business-review.com/news/calcimedica_exercises_option_to_acquire_intellectual_property_from_torreypines/ 2018-07-04T15:29:28+00:00 https://www.pharmaceutical-business-review.com/news/celgene-exercises-option-to-extend-strategic-collaboration-scope-and-term-with-forma-therapeutics-300817-5912553/ 2018-07-04T15:29:31+00:00 https://www.pharmaceutical-business-review.com/news/genmab-seattle-genetics-to-co-develop-tisotumab-vedotin-for-solid-tumors-300817-5912546/ 2018-07-04T15:29:31+00:00 https://www.pharmaceutical-business-review.com/news/mercks-cardiovascular-treatment-anacetrapib-reduces-coronary-events-in-reveal-study-300917-5912328/ 2018-07-04T15:29:31+00:00 https://www.pharmaceutical-business-review.com/news/antares_pharma_names_new_chairman/ 2018-07-04T15:29:31+00:00 https://www.pharmaceutical-business-review.com/news/a94b0minrad_international_reduces_work/ 2018-07-04T15:29:32+00:00 https://www.pharmaceutical-business-review.com/news/34490duska_therapeutics_files_phase_iii_protocol_for_a/ 2018-07-04T15:29:32+00:00 https://www.pharmaceutical-business-review.com/news/d0498purdue_pharma_and_mundipharma_form_cancer_research_alliance_with_inf/ 2018-07-04T15:29:32+00:00 https://www.pharmaceutical-business-review.com/news/36492protherics_initiates_bla_submission_for_vor/ 2018-07-04T15:29:32+00:00 https://www.pharmaceutical-business-review.com/news/csl-to-acquire-us-based-hsc-gene-therapy-developer-calimmune-290817-5911146/ 2018-07-04T15:29:33+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-boston-pharmaceuticals-sign-deal-for-selective-ret-inhibitor-for-solid-tumors-290817-5911025/ 2018-07-04T15:29:34+00:00 https://www.pharmaceutical-business-review.com/news/xoma-announces-license-agreements-for-gevokizumab-and-its-il-1-beta-intellectual-property-portfolio-290817-5911010/ 2018-07-04T15:29:34+00:00 https://www.pharmaceutical-business-review.com/news/f14abeurand_names_new_chief_medical_of/ 2018-07-04T15:29:35+00:00 https://www.pharmaceutical-business-review.com/news/034b4ortho_biotech_files_new_drug_application_for_ovarian_cancer/ 2018-07-04T15:29:35+00:00 https://www.pharmaceutical-business-review.com/news/8048esupergen_wins_clearance_to_initiate_phase_i_cancer_/ 2018-07-04T15:29:35+00:00 https://www.pharmaceutical-business-review.com/news/b14bcresolvyx_announces_completion_of_fda_review_period_for_dry_eye/ 2018-07-04T15:29:35+00:00 https://www.pharmaceutical-business-review.com/news/a848ecook_medical_wins_conditional_approval_to_start_zenith_endovascular_graft_/ 2018-07-04T15:29:36+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-to-buy-us-firm-kite-pharma-for-119bn-290817-5910870/ 2018-07-04T15:29:38+00:00 https://www.pharmaceutical-business-review.com/news/cf-pharmtech-raises-65m-to-accelerate-development-of-its-inhalation-products-and-manufacturing-capacity-280817-5910385/ 2018-07-04T15:29:38+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-grants-approval-for-mavenclad-280817-5910369/ 2018-07-04T15:29:38+00:00 https://www.pharmaceutical-business-review.com/news/2f4beidri_and_immune_design_sign_licensing_agreement_for_gla_vaccine_adj/ 2018-07-04T15:29:39+00:00 https://www.pharmaceutical-business-review.com/news/2b49cluminex_and_mingyuan_sign_distribution_agre/ 2018-07-04T15:29:39+00:00 https://www.pharmaceutical-business-review.com/news/5c4b8aastrom_initiates_treatment_in_phase_ii_dilated_cardiomyopathy_/ 2018-07-04T15:29:39+00:00 https://www.pharmaceutical-business-review.com/news/samsung-bioepis-humira-biosimilar-imraldi-approved-in-europe-280817-5909978/ 2018-07-04T15:29:40+00:00 https://www.pharmaceutical-business-review.com/news/regenxbio-to-buy-us-firm-dimension-therapeutics-280817-5909718/ 2018-07-04T15:29:40+00:00 https://www.pharmaceutical-business-review.com/news/roche-secures-priority-review-from-fda-for-haemophilia-a-drug-emicizumab-240817-5908815/ 2018-07-04T15:29:40+00:00 https://www.pharmaceutical-business-review.com/news/d34afchmp_recommends_suspension_of_marketing_approval_for_i/ 2018-07-04T15:29:40+00:00 https://www.pharmaceutical-business-review.com/news/a44bbpar_pharmaceutical_stops_shipment_of_generic_budesonide_inhalation_suspe/ 2018-07-04T15:29:40+00:00 https://www.pharmaceutical-business-review.com/news/novartis-breast-cancer-drug-kisqali-secures-eu-approval-24-08-17-5909026/ 2018-07-04T15:29:43+00:00 https://www.pharmaceutical-business-review.com/news/apellis-apl-2-meets-primary-endpoint-in-phase-2-study-5909014/ 2018-07-04T15:29:43+00:00 https://www.pharmaceutical-business-review.com/news/cancer-research-uk-launches-clinical-trial-to-test-new-cancer-drug-240817-5908743/ 2018-07-04T15:29:43+00:00 https://www.pharmaceutical-business-review.com/news/ea4b0arcutiss_nda_for_acne_drug_wins_fda_app/ 2018-07-04T15:29:43+00:00 https://www.pharmaceutical-business-review.com/news/fb4b3epeius_reports_encouraging_results_from_phase_iii_and_ii_sarcoma_st/ 2018-07-04T15:29:43+00:00 https://www.pharmaceutical-business-review.com/news/2e48aidera_and_merck_extend_research_collabor/ 2018-07-04T15:29:43+00:00 https://www.pharmaceutical-business-review.com/news/4d4bbscs_signs_service_agreement_with_p/ 2018-07-04T15:29:44+00:00 https://www.pharmaceutical-business-review.com/news/c648dpfizer_withdraws_application_for_otc_viagra_/ 2018-07-04T15:29:44+00:00 https://www.pharmaceutical-business-review.com/news/c14aeelan_names_new_pres/ 2018-07-04T15:29:46+00:00 https://www.pharmaceutical-business-review.com/news/ultragenyx-ace-er-fails-in-phase-3-gne-myopathy-trial240817-5908724/ 2018-07-04T15:29:47+00:00 https://www.pharmaceutical-business-review.com/news/epygenix-gets-fda-orphan-drug-status-for-epx-300-to-treat-dravet-syndrome-240817-5908023/ 2018-07-04T15:29:47+00:00 https://www.pharmaceutical-business-review.com/news/viracyte-announces-positive-phase-2-trial-results-230817-5907417/ 2018-07-04T15:29:47+00:00 https://www.pharmaceutical-business-review.com/news/324b5fda_accepts_vandas_iloperidone_nda_resubmi/ 2018-07-04T15:29:47+00:00 https://www.pharmaceutical-business-review.com/news/7a4b6visualsonics_and_seno_medical_sign_licensing_agre/ 2018-07-04T15:29:47+00:00 https://www.pharmaceutical-business-review.com/news/a2483bmp_sunstone_acquires_runchang_ca/ 2018-07-04T15:29:47+00:00 https://www.pharmaceutical-business-review.com/news/3c4a9radius_health_raises_additional_15_million_in_equity_fina/ 2018-07-04T15:29:48+00:00 https://www.pharmaceutical-business-review.com/news/grid-therapeutics-signs-exclusive-license-agreement-to-develop-novel-immuno-oncology-antibody-230817-5907397/ 2018-07-04T15:29:50+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-initiates-phase-1-trials-of-zealands-analogs-for-obesity-and-diabetes-230817-5907360/ 2018-07-04T15:29:50+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-led-consortium-begins-trial-of-metastatic-breast-cancer-treatment-palbociclib-230817-5906843/ 2018-07-04T15:29:50+00:00 https://www.pharmaceutical-business-review.com/news/02490incode_biopharmaceutics_names_new_president_an/ 2018-07-04T15:29:52+00:00 https://www.pharmaceutical-business-review.com/news/a54adimclone_systems_wins_fda_approval_for_manufacturing_fac/ 2018-07-04T15:29:52+00:00 https://www.pharmaceutical-business-review.com/news/e14b3uk_government_announces_new_pharmaceutical_price_regulation_sch/ 2018-07-04T15:29:52+00:00 https://www.pharmaceutical-business-review.com/news/c4494akorn_signs_five_year_contract_manufacturing_agre/ 2018-07-04T15:29:53+00:00 https://www.pharmaceutical-business-review.com/news/ef480biovitrum_reports_positive_results_from_rhimmunization_prevention_/ 2018-07-04T15:29:53+00:00 https://www.pharmaceutical-business-review.com/news/ovid-therapeutics-recruits-first-patient-in-phase-1b2a-trial-of-tak-935ov935-in-adults-with-rare-epilepsies-220817-5905976/ 2018-07-04T15:29:55+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-grants-new-indication-for-soliris-to-treat-refractory-generalized-myasthenia-gravis-220817-5905965/ 2018-07-04T15:29:55+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-medimmune-ethris-to-develop-mrna-therapies-for-respiratory-diseases-220817-5905579/ 2018-07-04T15:29:55+00:00 https://www.pharmaceutical-business-review.com/news/ed4bdgenelink_expands_testing_capabil/ 2018-07-04T15:29:55+00:00 https://www.pharmaceutical-business-review.com/news/8f48castrazeneca_to_divest_swedish_otc_portfolio_to_glaxosmith/ 2018-07-04T15:29:56+00:00 https://www.pharmaceutical-business-review.com/news/a5482patheon_signs_master_service_agreement_with_omnicare_clinical_res/ 2018-07-04T15:29:56+00:00 https://www.pharmaceutical-business-review.com/news/ff4bdkaro_bio_and_wyeth_form_collabor/ 2018-07-04T15:29:56+00:00 https://www.pharmaceutical-business-review.com/news/fc4aditamar_medical_names_ne/ 2018-07-04T15:29:56+00:00 https://www.pharmaceutical-business-review.com/news/70496pacificgmp_and_actinium_sign_contract_manufacturing_agre/ 2018-07-04T15:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ef499debiopharm_and_aurigene_sign_licensing_agre/ 2018-07-04T15:30:00+00:00 https://www.pharmaceutical-business-review.com/news/8a487solvay_signs_licensing_agreement_with_de/ 2018-07-04T15:30:00+00:00 https://www.pharmaceutical-business-review.com/news/3c4b7wyeth_names_new_president_of_technical_operations_and_product_s/ 2018-07-04T15:30:01+00:00 https://www.pharmaceutical-business-review.com/news/4c4bcjazz_and_ucb_report_positive_results_from_phase_iii_fibromyalgia_/ 2018-07-04T15:30:01+00:00 https://www.pharmaceutical-business-review.com/news/064b6gsk_wins_fda_approval_for_platelet/ 2018-07-04T15:30:04+00:00 https://www.pharmaceutical-business-review.com/news/9c49ccougar_biotechnology_initiates_enrollment_in_phase_iii_breast_cancer_/ 2018-07-04T15:30:04+00:00 https://www.pharmaceutical-business-review.com/news/7f48eambrilia_to_reduce_operations_in_f/ 2018-07-04T15:30:05+00:00 https://www.pharmaceutical-business-review.com/news/784adneuromed_completes_enrollment_for_phase_iii_chronic_low_back_pain_/ 2018-07-04T15:30:05+00:00 https://www.pharmaceutical-business-review.com/news/424adnnri_and_resolvyx_form_research_collabor/ 2018-07-04T15:30:05+00:00 https://www.pharmaceutical-business-review.com/news/bc4a2naviscan_wins_fda_clearance_for_stereo_navi/ 2018-07-04T15:30:07+00:00 https://www.pharmaceutical-business-review.com/news/1d481sanguine_to_acquire_rockland_tech/ 2018-07-04T15:30:08+00:00 https://www.pharmaceutical-business-review.com/news/824aeinvitrogen_introduces_new_in_vivo_rnai_delivery_re/ 2018-07-04T15:30:08+00:00 https://www.pharmaceutical-business-review.com/news/b44b2viral_genetics_acquires_vclip_pharmaceut/ 2018-07-04T15:30:08+00:00 https://www.pharmaceutical-business-review.com/news/65482synvista_files_510k_clearance_application_for_haptochek_test_/ 2018-07-04T15:30:08+00:00 https://www.pharmaceutical-business-review.com/news/c1487titan_medical_and_bell_canada_form_telesurgery_collabor/ 2018-07-04T15:30:11+00:00 https://www.pharmaceutical-business-review.com/news/15495teva_and_barr_sign_agreement_with_aventis_sanofiaventis_and_a/ 2018-07-04T15:30:11+00:00 https://www.pharmaceutical-business-review.com/news/554a4threshold_pharmaceuticals_names_new_board_m/ 2018-07-04T15:30:12+00:00 https://www.pharmaceutical-business-review.com/news/d2480gentium_receives_encouraging_review_from_dsmb_for_phase_iii_vod_/ 2018-07-04T15:30:12+00:00 https://www.pharmaceutical-business-review.com/news/244b0amgen_takeda_and_millennium_suspend_enrollment_in_phase_iii_lung_cancer_/ 2018-07-04T15:30:12+00:00 https://www.pharmaceutical-business-review.com/news/f0495synthemed_wins_fda_clearance_for_sinuss/ 2018-07-04T15:30:15+00:00 https://www.pharmaceutical-business-review.com/news/924b6nymox_announces_new_phase_iii_trials_of_bph/ 2018-07-04T15:30:15+00:00 https://www.pharmaceutical-business-review.com/news/5648badvitech_signs_collaboration_agreement_with_laboratories/ 2018-07-04T15:30:16+00:00 https://www.pharmaceutical-business-review.com/news/ed49dgenerex_wins_two_new_pain_relief_pa/ 2018-07-04T15:30:16+00:00 https://www.pharmaceutical-business-review.com/news/a04a7cryoport_and_advinus_therapeutics_form_collabor/ 2018-07-04T15:30:16+00:00 https://www.pharmaceutical-business-review.com/news/054b2febit_signs_technology_development_agreement_with_in/ 2018-07-04T15:30:19+00:00 https://www.pharmaceutical-business-review.com/news/09487roche_launches_new_nimblegen_cgh_microa/ 2018-07-04T15:30:19+00:00 https://www.pharmaceutical-business-review.com/news/42485sanofiaventis_settles_patent_infringement_lawsuits_with_barr_and/ 2018-07-04T15:30:19+00:00 https://www.pharmaceutical-business-review.com/news/85498bovie_medical_wins_fda_clearance_for_seer_tissue_resection_d/ 2018-07-04T15:30:20+00:00 https://www.pharmaceutical-business-review.com/news/0d4bapar_pharmaceutical_signs_distribution_agreement_with_astraz/ 2018-07-04T15:30:20+00:00 https://www.pharmaceutical-business-review.com/news/df488imclone_systems_initiates_enrollment_for_phase_ii_breast_cancer_/ 2018-07-04T15:30:24+00:00 https://www.pharmaceutical-business-review.com/news/f248celixir_reports_positive_results_from_phase_iii_diabetes_/ 2018-07-04T15:30:24+00:00 https://www.pharmaceutical-business-review.com/news/204a5arete_raises_167_million_in_fina/ 2018-07-04T15:30:24+00:00